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Pre-mRNA splicing is catalyzed by the spliceosome, a multimegadalton ribonucleoprotein 
(RNP) complex. It assembles anew on each pre-mRNA intron by the stepwise binding of 
five snRNPs (U1, U2, U4, U5 and U6) and numerous proteins leading to the formation of 
the spliceosomal complex B which does not have yet an active catalytic site. For the 
establishment of the active site major structural changes are required, resulting in the 
formation of the activated B complex (Bact), which is then converted into the catalytically 
activated B* complex by the action of the Prp2 RNA helicase. Following the recruitment 
of the splicing factor Cwc25, the first step of splicing occurs, whereby the 5' splice site of 
the pre-mRNA is cleaved and the 5' end of the intron is ligated to the branch site adenosine 
to form a lariat-like structure; concomitantly the C complex is formed. At this time the 
second step of splicing occurs which leads to exon ligation. The newly formed mRNP is 
released from the spliceosome and the intron lariat spliceosome is disassembled. The 
released snRNPs are thought to re-assemble for a new round of splicing. 
A complex RNA–RNA network involving the snRNAs and the pre-mRNA is formed 
during spliceosome assembly, and the resulting RNA structure plays a central role in 
catalysing the two steps of splicing. During spliceosome activation, U6 snRNA rearranges 
and forms an internal stem-loop (ISL) which plays a central role in the catalysis of 
splicing. The U6-ISL contains an internal bulge region that is critical for metal-ion binding 
and contains functionally important residues. U6 snRNA also forms base pairs with 
U2 snRNA generating the U2/U6 helix I. Finally, U6 snRNA via its conserved 
ACAGAGA sequence, also forms base pairs with the 5' end of the intron. In this 
arrangement, the branch site is juxtaposed with the 5' splice site.  
While the importance of individual RNA-structural elements such as U6-ISL, U2/U6 
helix I and the U6-ACAGAGA/5' splice site helix for splicing catalysis is well established, 
little was known at the time I started this work about how these various RNA elements are 
brought into a catalytically active tertiary conformation. Interestingly, if one examines 
how the catalytic center of the group II self-splicing introns is organized, a number of 
similarities between pre-mRNA and group II intron splicing can be recognized and 





systems. These include (i) the identical chemistry of the catalytic steps of both kinds of 
splicing and (ii) the great similarity between catalytically important structural elements in 
group II introns and the spliceosomal RNA network, especially between domain V (DV) 
of group II introns (which forms a stem-loop) and the U6-ISL, both of which bind 
catalytically active metal ions. One of the most impressive features revealed by the 
recently published crystal structure of an intact self-spliced group IIC intron is how 
numerous long-distance interactions between conserved structural elements of DI to VI 
and DV are essential to induce an unusual, catalytically important fold in DV. 
In view of the paucity of conserved RNA tertiary structures in spliceosomal introns that 
might direct the folding and juxtaposition of essential catalytic RNA-structural elements 
(i.e U6-ISL and U2/U6 helix I) into an active conformation, it seems likely that 
spliceosomal proteins may have taken over this function, at least in part. Good candidates 
would be one or more of those proteins that become stably integrated into the spliceosome 
during its activation (i.e., the formation of the Bact complex). In yeast, these include a 
protein complex termed the “nineteen complex” (NTC) that consists of eight core proteins, 
and an additional set of NTC-related proteins. Among these, the yeast Cwc2 protein was 
of particular interest since it has an RRM and a zinc-finger domain, is essential for 
pre-mRNA splicing in vivo and has been shown to contact U6 snRNA during splicing in 
yeast extracts.  
Here we show that Cwc2 is essential for the first step of splicing in vitro, and that it is not 
required for the Prp2-mediated remodelling step that generates the catalytically competent 
B* complex. We demonstrate that in purified catalytically active spliceosomes, Cwc2 
contacts the U6-ISL, as well as regions of the U6 snRNA and the intron adjacent to the 5' 
splice site. Chemical structure-probing further suggests that Cwc2 may also directly or 
indirectly contact U6/U2 helix I. Thus, our data place Cwc2 at the heart of the 
spliceosome's catalytic center. During this time the crystal structure of the Cwc2 
functional core was solved by our group, and could be used to determine structure-
function relationships by rational mutagenesis of Cwc2 combined with splicing. In 
addition, mass spectrometric analysis of RNA-protein crosslinks and electrophoretic 
mobility shift assays (EMSA) showed that Cwc2 acts as a multipartite RNA binding 






Interestingly, we also show that RNA interactions involving Cwc2 are evolutionarily 
conserved, as demonstrated by studies of its human counterpart RBM22, indicating that 
the observed Cwc2/RBM22 RNA contacts in the spliceosome are functionally important. 
We propose that Cwc2, in co-operation with the essential splicing factor Prp8, induces an 
active conformation of the catalytic RNA elements in the spliceosome. In conclusion, our 
data suggest that the function of RNA-RNA tertiary interactions within group II introns, 
that is, to induce a catalytically active RNA conformation of DV, has probably been taken 








1.1 Mosaic structure of eukaryotic genes and RNA splicing 
 
The central dogma of molecular biology stated by Francis Crick in 1970 (Crick, 1970) 
describes the transfer of information encoded within DNA into a specific amino acid 
sequence, called protein. During this process, DNA is transcribed first into RNA by an 
enzyme called RNA polymerase. In a process named translation, a macromolecular 
structure, the ribosome, subsequently converts the RNA sequence into an amino acid 
polymer. While the flow of information between DNA and RNA can proceed in both 
directions, a protein sequence cannot be retranslated. 
In eukaryotic cells at first the DNA is usually transcribed into a precursor messenger RNA 
(pre-mRNA) containing large non-coding sequences (introns). During a process called 
RNA splicing, introns are removed from the transcripts and the coding sequences (exons) 
are ligated together. RNA splicing is accomplished by one of the largest and most complex 
cellular machineries, the spliceosome. Only after that pre-mRNA transcripts undergo RNA 
splicing and acquire two additional major modifications-, (i.e. 5’capping and 
3’polyadenylation), the mature mRNA is exported to the cytoplasm to be translated. 
    
 
1.2 Pre-mRNA splicing 
 
From the chemical point of view the splicing reaction as such is very simple. Nevertheless, 
in vivo the spliceosome has to select the correct splice sites very precisely because even a 
mistake of one single nucleotide would result in a frameshift which could change the 
complete open reading frame (ORF) of the transcript. Especially in higher eukaryotes, as 
in humans, exons often are very short (~50 bases on average) compared to much longer 
introns (~3500 bases in average), which can reach up to more than 100 kb in length and 
can count up to 116 introns per gene (Deutsch & Long, 1999). Under this perspective it is 
very demanding for the spliceosome to recognize the exact boundaries of an exon and 








In the yeast Saccharomyces cerevisiae (S. cerevisiae) these cis-acting elements are highly 
conserved (Figure 1.1). The 5’ splice site (5’SS) sequence defines the boundary between 
an exon and a downstream intron and is composed of R/GUAUGUU (‘R’ is a purine, ‘/’ 
indicates the exon/intron boundary)(Lopez & Seraphin, 1999). While in S. cerevisiae the 
5’SS is 90% conserved, the human consensus sequence AG/GURAG is rather degenerate.  
The 3’splice site (3’SS) sequence defines the boundary between an intron and a 
downstream exon and is composed of YAG/ (‘Y’ is a pyrimidine, ‘/’ indicates the 
exon/intron boundary) in S. cerevisiae as well as in H. sapiens. In many introns the 3’SS is 
preceded by a stretch of 8-12 pyrimidines called the polypyrimidine tract, which usually 
ends one nucleotide upstream of the 3´SS. The polypyrimidine tract seems to be more 
important for splicing of human than for splicing of yeast introns. 
Another conserved sequence element surrounds the adenosine (branch adenosine, branch 
point, BP) which forms a branched intermediate in the course of the first step of splicing. 
This sequence is therefore called branch point sequence (BPS). The consensus sequence is 
composed of UACUAAC and in yeast it is usually located 10-60 nucleotides upstream of 
the 3’SS (Spingola et al, 1999). 
In contrast to H. sapiens the majority of genes from S.cerevisiae do not contain introns. 
Only about 250 of the 6000 genes were found to be interrupted by non-coding sequences. 
Nevertheless, most of those genes encode ribosomal proteins, thus intron containing 
transcripts are highly abundant within the yeast cell. Therefore, almost 30% of all 
Figure 1.1: Comparison of conserved sequence elements between introns from S. cerevisiae and 
H. sapiens 
Nucleotides with 90% or higher conservation are shown in bold. The BP adenosine is underlined. The 
polypyrimidine tract is represented by (Yn); purines are shown with ‘R’; ns = nucleotides. The scheme is 





transcripts undergo splicing although only approximately 4% of yeast genes contain 
introns. 
In contrast to H. sapiens yeast introns are usually much shorter (100-400 nts) and there are 
only very few examples where pre-mRNAs are differentially spliced, a process referred to 
as alternative splicing. Alternative splicing is very common in H. sapiens and leads to a 
much higher diversity of gene products from only a limited number of genes. 
 
 
1.3 Chemistry of the splicing reaction 
 
The excision of introns from pre-mRNA requires two distinct transesterification reactions 
(Moore & Sharp, 1993). First, the 2’-hydroxyl group of the branch point adenosine carries 




Figure 1.2: Chemistry of the splicing reaction 
RNA splicing proceeds via two consecutive transesterification reactions, leading to the excision of the 
lariat intron and the joining of the exons. 
 
 mRNA  lariat intron 





pre-mRNA into the 5’ exon and a lariat structured intermediate (Figure 1.2). In the second 
step, the phosphorus atom at the 3’SS is attacked by the nascent 3’-hydroxyl group of the 
5’ exon, displacing the bond to the lariat intron and thereby joining the 5’ and 3’ exons to 
form the mature mRNA product. The transesterification reactions as such are essentially 




1.4 Composition of snRNPs 
 
In eukaryotes pre-mRNA splicing is catalyzed by the spliceosome, a large ribonuclear 
complex. In contrast to the ribosome which, once bound to its substrate, shows a high 
degree of processivity, the spliceosome assembles anew on each pre-mRNA. The 
assembly and disassembly of the spliceosome is therefore organized in a very dynamic 
manner. 
 
The spliceosome is formed from several subunits, referred to as small nuclear 
ribonucleoproteins (snRNPs), and various non-snRNP splicing factors. Each snRNP 
consists of an RNA, namely U1, U2, U4, U5 or U6 snRNA, and several protein factors. 
Except for U6, these snRNAs are transcribed by the RNA polymerase II as snRNA 
precursors containing additional 3’ nucleotides and a monomethylated m7G cap structure. 
These pre-snRNAs are then exported into the cytoplasm where the snRNP assembly is  
S. cerevisiae H. sapiens 
        
snRNA length(nts) snRNA length(nts) 
        
U1 568 U1 164 
U2 1175 U2 187 
U4 160 U4 145 
U5L 214 - - 
U5S 179 - - 
U6 112 U6 106 
 
Table 1.1: Spliceosomal RNAs in S. cerevisiae and H. sapiens 








Figure 1.3: Secondary structures for the yeast U snRNAs 
Schematic representation of proposed secondary structures of yeast snRNAs. The Sm binding site is indicated with a 
grey shadow. The conserved ACAGA box motif in U6 snRNA is underlined. Adapted from Kretzner et al 







           
Table 1.2: Protein composition of snRNPs from S.cerevisiae and H. sapiens 
Shown are the Sm proteins, common to the U1, U2, U4, and the U5 snRNP as well as the Lsm proteins for the 







initiated. The snRNA precursors assemble in a stepwise manner with a group of seven 
proteins referred to as the Sm proteins, namely B/B’, D3, D2, D1, E, F and G. In this 
process the Sm proteins build a ring like formation around a conserved sequence element 
within the pre-snRNAs and thereby form the snRNP core structure. Subsequently to the 
Sm core assembly, the m7G cap is hypermethylated into a 2,2,7-trimethylated cap (m3G) 
structure and the pre-snRNAs undergo 3’ end processing. The m3G cap in conjunction 
with the Sm core acts as a nuclear localization signal which is required for the subsequent 
import into the nucleus. The assembly of U6 snRNP is thought to take place entirely 
within the nucleus. U6 snRNA is transcribed by RNA polymerase III and is 
monomethylated at its 5’ γ-phosphate. The U6 snRNA lacks a Sm site and therefore the 
core structure of U6 is comprised of a set of protein factors referred to as LSm proteins, 
namely LSm2, LSm3, LSm4, LSm5, LSm6, LSm7 and LSm8. LSm proteins share 
conserved structural motifs with the Sm proteins and interact with a uridine rich tract at 
 
Figure 1.4: Protein and snRNA composition of U snRNPs from S. cerevisiae 
 
S. cerevisiae snRNA structures are shown as colored lines and intermolecular basepairing interactions are 
indicated by dashes. The common Sm/Lsm proteins are highlighted in grey, and particle-specific proteins 
are assigned to the corresponding snRNA through the same color code. Typical snRNP subcomplexes are 
represented as colored circles at the top of this illustration (This figure was kindly provided by Dr. 







the 3’ end of U6 snRNA. In Table 1.1 the spliceosomal snRNAs of S.cerevisiae and H. 
sapiens are listed. Note that there are two isoforms of U5 snRNA in S. cerevisiae referred 
to as U5 long (U5L) and U5 short (U5S). Both originate from the same primary transcript 
but are differentially processed at their 3’ end.  
Phylogenetic comparative methods have shown a high degree of sequence conservation 
between snRNAs from different species. Especially stretches known to be involved in 
interactions with pre-mRNA, proteins or other snRNAs are highly conserved. This 
conservation is also reflected in very similar models of secondary structure (Figure 1.3).   
In addition to the core components mentioned above which are common among different 
snRNPs, each snRNP is also composed of particle specific factors listed and schematically 
presented in Figure 1.4. The topic of this work mainly focuses on pre-mRNA splicing in 
the yeast S. cerevisiae where many of the proteins related to splicing are named “Prp” 
proteins to indicate their function in pre-mRNA processing. 
    
 
1.5 Spliceosome assembly in Saccharomyces cerevisiae 
 
The current understanding of spliceosome assembly is mainly based on biochemical 
studies of in vitro splicing systems. Using a combination of native gel electrophoresis, 
glycerol gradient centrifugation and affinity selection, it was possible to isolate and 
characterize defined spliceosomal assembly intermediates. On the basis of these 
investigations a stepwise model of spliceosome assembly is widely accepted today.  
A scheme of the stepwise assembly of spliceosomes from S. cerevisiae is shown in Figure 
1.5. First, the U1 snRNP is recruited to the 5’SS in a process which in part is mediated 
through base-pairing of the 5’ end of U1 snRNA with the conserved nucleotides of the 
5’SS. In an ATP dependent step the U2 snRNP binds to the branch point region thus 
forming complex A. The U2 snRNP is anchored to the BPS via base-pairing of the U2 
snRNA with intron sequences (Madhani & Guthrie, 1994a) and binding of several protein 
factors primarily upstream of the BPS (Gozani et al, 1996; Gozani et al, 1998). In the next 
step the preformed U4/U6.U5 tri-snRNP is recruited to complex A, forming complex B. 
Although complex B contains a full set of snRNPs it is not catalytically active yet. The 
transformation of the pre-catalytic spliceosome into the catalytically active complex 





ATPases/helicases. As indicated in Figure 1.5 DExD/H box type ATPases/helicases are 
essential for several steps of splicing and therefore their function will be described more 
extensively in chapter 1.7. During activation of the spliceosome and transition from  
 
 
complex B to complex Bact, the U1 and U4 snRNPs are released. The complex Bact is then 
catalytically activated by Prp2 to form complex B*, which catalyzes the first step of 
splicing thereby generating complex C. Prior to the second step of splicing the 
spliceosome once more undergoes a major remodeling event which leads to 
rearrangements at the catalytic center which are required for exon ligation and also to 
assist with splicing fidelity (Konarska et al, 2006). After the release of the mature mRNA, 





Figure 1.5: Spliceosome assembly in S. cerevisiae 
Schematic presentation of the stepwise assembly of the spliceosome on a pre-mRNA. U snRNPs are 
represented as circles labeled with the respective U snRNA. Helicases, required for important remodeling 
events are indicated. Recycling of snRNPs is indicated by grey arrows. Spliceosomal complexes are named 






1.6 Dynamics of the spliceosomal RNA-network 
 
During spliceosome assembly, a complex RNA-network is formed involving intra- and 
intermolecular interactions between snRNAs, as well as interactions between snRNAs and 
the pre-mRNA (Staley & Guthrie, 1998; Wahl et al, 2009). During the splicing cycle the 
RNA network undergoes several major structural rearrangements. Initially, U1 recognizes 
the 5’SS while U2 forms a short duplex with the BPS. In this duplex the branch point 
adenosine is bulged out, enabling it to carry out the nucleophilic attack during the first step 
of splicing. Within the tri-snRNP, U4 and U6 are extensively base paired. This interaction 
has to be disrupted upon integration into complex A, allowing U6 to replace U1 at the 
5’SS. In this process U6 forms base pairs with the 5’ end of the intron via its conserved 
ACAGAGA motif. In addition, U6 is now able to form short duplexes with U2, namely 
helix Ia, Ib and II. Helix Ib contains the invariant AGC triad of U6 that has been suggested 




Figure 1.6: Dynamics of the spliceosomal RNA network during catalytic activation 
Schematic representation of the RNA rearrangements occuring within the spliceosomal RNA network during 
spliceosome activation. Left: pre-catalytic spliceosome, B complex; right: catalytically activated spliceosome 
before the first catalytic step, B* complex. Important RNA regions are assigned by their sequence content in 
Latin letters or in case of U6 snRNA with colored lines (yellow line: sequence forming the U6-ISL after 
catalytic activation, red line: region involved in basepairing interactions with U2 (helices Ia and Ib, indicated 
with the primary sequence on the right). The branchpoint A is highlighted in red and is bulged out from the 






Through the interaction of U6 with U2 the BP is brought in proximity to the 5’SS.The 
release from U4 also allows U6 to adopt an intramolecular stem loop structure (U6-ISL), 
comprising a bulge loop coordinating a Mg2+ ion which is crucial for the catalysis of the 
splicing reaction (Yean et al, 2000).   
Upon integration of the tri-snRNP, loop I of U5 contacts exon nucleotides upstream of the 
5’SS. After the first step of splicing, the U5 loop I extends its interaction to exon 
nucleotides downstream of the 3’SS. Most probably these interactions are required to align 
both exons for catalysis of the second step of splicing.  
The RNA network shaped through all these described remodeling events (Figure 1.6, B*- 
catalytically activated spliceosome) forms the core of the catalytic center of the 
spliceosome and, in addition, the necessity of Mg2+ ions for the catalysis of the splicing 
reaction suggests an RNA based catalysis which could be similar to the mechanism 
depicted for group II selfsplicing introns (see also chapter 1.9 for more details).  
 
 
1.7 DExD/H box helicases 
 
Due to the dynamic character of the splicing reaction at several stages of spliceosome 
assembly, active driving forces are required for rearrangements of the RNA network or to 
separate interaction partners allowing them to form new contacts. Some members of the 
family of DExD/H-type RNA-depended ATPases have been found to be crucial for a 
number of steps throughout the whole splicing cycle. In general, this type of enzyme was 
shown to be involved in almost every aspect of RNA metabolism (Cordin et al, 2012) by 
catalyzing reactions like the separation of double stranded RNA or the displacement of 
proteins from RNA (Fairman et al, 2004). In the spliceosomal context at least eight 
ATPases of the DExD/H-type, conserved between human and yeast, have been described 
so far (Table 1.3).  
At the early stages of spliceosome assembly Sub2 and Prp5 are required to facilitate the 
interaction of the U2 snRNP with the BPS. In this context it is assumed that Sub2 might be 
responsible for the displacement of SF1 from the BP to open this region for interactions 
with the U2 snRNP (Staley & Guthrie, 1998; Wahl et al, 2009). For Prp5 it was suggested 
that it interacts with SF3a components to facilitate an ATP-dependent remodeling of the 





the BPS (Abu Dayyeh et al, 2002; Wiest et al, 1996). Prp5 might also be required to 
monitor the fidelity of base pairing in the branch region (Xu & Query, 2007). During 
catalytic activation several interactions formed in the early assembly stages of the 
spliceosome have to be broken again. The ATPase Prp28 is involved in the release of U1 
snRNP to free the 5’SS for interactions with the U6 snRNA. At approximately the same 
time U6 and U4 snRNA have to be dissociated since they are still tightly base paired 
within the tri-snRNP. The helicase Brr2 is responsible for the unwinding of U6 and U4 
snRNA to promote base-pairing of U6 with U2 snRNA. Since Brr2 stays associated with 
the spliceosome and is required again during disassembly its activity needs to be strictly 
controlled (Small et al, 2006). In summary, the combined action of these enzymes yields 
the Bact complex. The final catalytic activation of Bact to yield B*, requires the RNA 
helicase Prp2. The B* complex catalyses step 1 of splicing, yielding the C complex. After 
a further remodelling step, which requires the RNA helicase Prp16, complex C catalyses 
the second step. 
 
Before the second step of catalysis can occur, the action of the helicase Prp16 is required. 
Prp16 was isolated as a suppressor of a branch A to branch C mutation of the pre-mRNA 
substrate, thus it affects the fidelity of branch site usage (Cordin et al, 2012). Only 
recently, it was shown to mediate the release of the spliceosomal first step proteins Cwc25 
and Yju2 to allow the binding of the second step proteins Prp22, Prp18 and Slu7 (Tseng et 
al, 2011). Recent experiments performed in our department however showed that under 
physiological salt concentrations (75 mM KCl), the addition of Prp16 and ATP to the C 
 
Table 1.3: Spliceosomal ATPases from S.cerevisiae and H. sapiens 
Spliceosomal helicases conserved between S. cerevisiae and H. sapiens. The function of each ATPase is 





complex does not lead to the release of Cwc25 directly. Only the further addition of Slu7 
and Prp18 leads to a quantitative dissociation of Cwc25 from the spliceosome concomitant 
with step 2 catalysis (Odenwälder et al., in preparation).  
Subsequent to the ligation of the exons the mRNA is released from the spliceosome in a 
process driven by the helicase Prp22 (Company et al, 1991; Schwer & Gross, 1998). 
Genetic analysis implicate that Prp22 is involved in breaking contacts between Prp8 and 
the conserved loop 1 of U5 snRNA (Aronova et al, 2007; Schneider et al, 2004) and 
thereby separating the U5 snRNP and the mRNA. After the release of the mRNA, the 
intron-lariat complex is disassembled by the action of Prp43 enabling the associated 
spliceosomal snRNPs to participate in another round of splicing (Arenas & Abelson, 
1997).      
It has been shown that several DExD/H-box helicases such as Prp5, Prp2, Prp16 and 
Prp22 couple rearrangements of RNPs with proofreading functions that ensure the 
accurate succession of the splicing process and allow for the rejection of substrates or 
intermediates that are aberrant. In this context a two-state model for the spliceosome is 
discussed. Since the substrates for the two chemical reactions are different, at least a 
partial rearrangement of the substrate(s) and/or enzyme at the catalytic center is required 
to reposition the splicing intermediates generated during the first catalytic step, so that the 
reactive groups involved in the second step are brought into the right conformation for the 
second step. Therefore, the spliceosome most probably can alternate between two discrete 
conformational states during the catalytic phase, binding the substrates differently for the 
two steps (Konarska & Query, 2005b). This hypothesis is mainly based on several 
mutations in spliceosomal factors (Prp8, Prp16, U6 snRNA, Isy1) which were shown to 
alter the relative efficiencies of the first and second steps. Therefore it has been suggested 
that the catalytic center of the spliceosome may alternate between two different states 
during the catalytic phase. It has also been suggested that the first and second catalytic 
steps require different conformational states of the spliceosome during the catalytic phase 
(Konarska & Query, 2005b). Since the ATPases Prp2 and Prp16 are essential for the 
activation of the spliceosome prior to the first and second catalytic steps, respectively, it 
seems likely that the equilibrium between these conformational states is modulated by 
these factors. In particular, the ATPase Prp16 promotes the transition between the first and 
second steps, and thereby it provides an opportunity for discarding aberrant substrates that 
do not proceed efficiently to the second step. This modulation of transition and 









1.8 Dynamics of the spliceosomal protein composition 
 
Although there is evidence that the splicing reaction per se might be RNA catalyzed, 
proteins account for a major component of the spliceosome and can make up more than 
two thirds of its total mass. First analysis of mixed populations of complete spliceosomal 
complexes revealed that next to known snRNP protein factors also numerous non-snRNP 
factors are associated with the spliceosome. However, the recent possibility of purifying 
spliceosomal complexes at defined stages provided not only an insight into the complete 
protein composition but also into protein dynamics during spliceosome assembly (Fabrizio 
et al, 2009). Mass spectrometric analysis revealed substantial changes in the protein 
composition of spliceosomal complexes between different stages of assembly (Figure 1.7).   
It was shown that at the stage of complex B not only the preformed tri-snRNP is recruited 
to the spliceosome but also several non-snRNP proteins. A complex termed “nineteen 
complex” (NTC) joins, which consists of Prp19, Cef1, Snt309, Syf1, Clf1, Isy1, Ntc20 and 
Syf2 which is required for promoting stable interactions of U5 and U6 snRNAs with the 
pre-mRNA during the activation of the spliceosome (Chan & Cheng, 2005; Chan et al, 
2003). Together with the NTC also the factors Prp45 and Prp46 and the RES complex 
(retention and splicing) are found to be components of complex B. However, at the stage 
of complex B these factors are present in substoichiometric amounts and only during the 
transition from complex B to Bact the NTC, Prp45, Prp46 and the RES complex become 
stably associated with the spliceosome. During this transition also 35 protein factors are 
released from the spliceosome, including tri-snRNP specific factors and all proteins 
associated with U1 and U4/U6. At the same time a set of additional proteins (Ecm2, 
Cwc2, Cwc15, Bud31, Yju2, Prp17, Cwc21, Cwc22, Cwc24, Cwc27) is recruited 
(Fabrizio et al, 2009). For simplicity, the latter group will henceforth be termed “NTC-
related proteins”, because several of them have been shown to interact loosely with one or 
more of the NTC core proteins. Like the NTC related proteins also the DEAH helicase 
Prp2 and its cofactor Spp2 associate with the spliceosome at the stage of Bact complex. 






rather needed purely mechanistically. Using an in vitro complementation system it was 





Figure 1.7: Compositional dynamics of yeast spliceosomes (adapted from Fabrizio et al (2009)) 
Protein composition of distinct spliceosomal complexes determined by mass spectrometry. Affiliation to 
respective U snRNPs is indicated above the boxes. The Prp19 complex is shown in red. Other proteins are 
classified according to their specific recruitment to the spliceosome at a certain stage of spliceosomal 
assembly cycle, i.e. Bact complex and C complex proteins, indicated in brown and purple, respectively. 
Recruitment and release of proteins is depicted by grey arrows. Schematic representations of B, Bact and C 





transforms Bact into a catalytically active complex named B*. If this complex is 
supplemented with Cwc25, efficient catalysis of step I can occur (Warkocki et al, 2009). 
However, Cwc25 is not associated with Bact complexes but most probably is recruited to 
the spliceosome during its catalytic activation just prior to step 1. Prp2 and Spp2 are found 
to be less abundant in complex C suggesting that both proteins are released from the 
spliceosome during the transition from Bact to C complex. Interestingly, also a 
destabilization of the U2 associated SF3a/SF3b proteins is observed during this transition, 
indicating that upon Prp2 remodeling, the region around the BPS might be rearranged to 
position the BP adenosine for the nucleophilic attack at the 5’SS. Besides Prp2, Spp2 and 
the U2 factors also Cwc24, Cwc27 and the members of the RES complex (Bud13, Pml1, 
Ist3) are less abundant in C complex.  
 
Nevertheless, a set of proteins not found in B and Bact complexes is recruited to the 
spliceosome at the stage of C complex. These include Cwc23 and Cwc25, the second step 
factors Slu7, Prp22, Prp18 and Prp16 and the disassembly factors Prp43, Ntr1 and Ntr2. 
Prp16 is represented in substoichiometric amounts within the C complex indicating that it 
might be only transiently associated with the spliceosome. Note that Prp17, another step 2 
 
Figure 1.8: Pre-mRNA constructs used for the purification of spliceosomes (adapted from Fabrizio et 
al, 2009) 
M3-Act wt is used to assemble either complex B under low ATP concentrations or Bact/B* complex after 
the heat inactivation of Prp2. M3-ActD6 is truncated six nucleotides downstream of the BPS and is used to 
stall Bact complexes while M3-ActD31 is truncated 31 nucleotides after the BPS and stalls spliceosome 






factor, was already present in Bact complexes. To isolate spliceosomal complexes at these 
defined stages, different pre-mRNA constructs are used (Figure 1.8). The M3Act∆6 pre-
mRNA is truncated 6 nucleotides after the BPS and is used to stall spliceosome assembly 
at the stage of Bact complex while the M3Act∆31 construct contains 31 nucleotides after 
the BPS, resulting in a block of splicing at the stage of complex C. B* complexes are 
purified employing an in vitro reconstitution system which is based on the temperature 
sensitivity of the DEAH box helicase Prp2. In yeast extract derived from a strain carrying 
the temperature sensitive mutant of Prp2, Prp2 can be inactivated by heat treatment.  
 
 
Figure 1.9: Three step purification of spliceosomal complexes 
In vitro splicing was carried out using yeast whole cell extract and one of the pre-mRNA constructs shown 
in Figure 1.8. The reactions were first separated via glycerol gradient centrifugation and subsequently 
purified on an amylose matrix. A second glycerol gradient centrifugation was carried out if very high 
purity was required. (This figure was kindly provided by Dr. Patrizia Fabrizio, department of cellular 





Splicing in extract lacking the function of Prp2 results in a complete arrest of spliceosome 
assembly at the level of Bact complex (named Bact∆Prp2) even if M3ActWT pre-mRNA is 
used, which in a wild type extract is capable of undergoing both steps of splicing. Purified 
Bact∆Prp2 spliceosomes can be supplemented with recombinant Prp2 and Spp2 in the 
presence of ATP to yield B* complexes which upon addition of Cwc25 undergo step 1.     
In vitro assembled spliceosomal complexes are purified by glycerol gradient 
centrifugation followed by affinity chromatography (Figure 1.9). If required also a second 
glycerol gradient can be performed subsequent to the affinity chromatography step.  
 
 
1.9  Similarities between the spliceosome and group II introns  
 
Group II introns are self-splicing ribozymes that catalyze their own excision from pre-
mRNAs (Pyle & Lambowitz, 2006). They usually contain an intron-encoded reverse 
transcriptase enabling them to act as retroelements and thereby integrating into the 
genome through reverse splicing reactions (Robart et al, 2007; Zimmerly et al, 1995). 
Group II introns were found in bacteria (Ferat & Michel, 1993), in the organellar genomes 
of plants, fungi, protists, and some animals (Pyle & Lambowitz, 2006; Valles et al, 2008). 
Founded on structural and sequence similarities it is assumed that eukaryotic spliceosomes 
and group II introns share a common ancestor.  
In general, group II introns consist of two major elements, a selfsplicing ribozyme and the 
gene encoding the reverse transcriptase. The ribozyme is composed of six domains. 
Domain I (DI), being the largest, acts as a scaffold and is thereby determining the overall 
intron shape and arranging important interactions. DI for example contains recognition 
sequences for binding the 5’ and 3’ exons and the BS nucleophile (Costa et al, 2000; 
Jacquier & Michel, 1987). Domain II (DII) directs the folding of the junction (J2/3) 
between DII and domain III (DIII) which is one of the most conserved elements within 
group II introns and a major component of the active site. DII also helps to integrate DIII 
into the ribozyme core where DIII is stimulating the splicing efficiency (Fedorova et al, 
2003). Domain IV (DIV) contains the open reading frame for the reverse transcriptase 
(RT) and also the primary binding sites for the RT (Wank et al, 1999).  
Domain VI (DVI) contains the adenosine acting as the nucleophile during the first step of 






The most conserved region within group II introns is domain V (DV), a 30-34 nts stem-
loop structure. A recent high resolution crystal structure of a group IIC intron from 
Oceanobacillus iheyensis confirmed that DV is located in the center of the intron where a 
network of interactions between DV and DI builds the active site. In this context DI acts as 
scaffold which arranges DV in a catalytically active conformation (Figure 1.10, Figure 
 
Figure 1.10: Overall secondary structure of the group II intron from Oceanobacillus iheyensis 
(adapted from (Toor et al, 2008a)) 
Secondary structure reflecting the coaxial stacking and domain organization evident from the introns crystal 
structure (Toor et al, 2008a). Watson-Crick tertiary interactions, base triples, and basestacking contacts are 







1.11). Some of the most important interactions of DI with DV are shown in a close-up 
view of DV (Figure 1.12).  
The terminal loop region of DV is arranged by the ζ-ζ’ interaction and the EBS1 (exon 
binding sequence) motif, while the z-anchor motif makes multiple contacts with loop I(i) 
of DI, the 5′ end of the intron and the upper part of the DV stem. In this way these regions 
are brought in close proximity to each other allowing for example the conserved G5 to 
contact A376 within helix of DV. This interaction is required to extrude A376 from the 
DV bulge. Five base pairs away from this two-nucleotide bulge the so called “catalytic 
 
Figure 1.11: Overall structure of the group IIC intron from O. iheyensis in a surface representation 
DV (red) is enclosed by the large cavity of the intron and crucial tertiary interactions of DV with several 
distant elements of the intron are indicated. Active site Mg2+ ions are shown as grey spheres. This figure is 





triad” is located. On the basis of mutagenesis and chemical interference studies it has been 
suggested that like the bulge also the catalytic triad coordinates catalytic Mg2+ (Gordon & 
Piccirilli, 2001; Sigel et al, 2000). Additionally, the catalytic triad forms a triple helix with  
the J2/3 and together with the bulge, these three elements form a major component of the 
active site (Boulanger et al, 1995; de Lencastre et al, 2005; Eldho & Dayie, 2007). 
Interestingly, the crystal structure shows that the angle between the upper and the lower 
stem of DV is approximately 45°, resulting in a bend of the RNA structure in a way that 
the DV bulge and the catalytic triad are closer to each other, namely approximately 3Å 
apart. This proximity between the bulge and the catalytic triad allows the formation of a 
negatively charged pocket that binds the two catalytic Mg2+ ions. As a result of this 
bended arrangement the distance between the two metal ions is 3.9 Å, a distance which 
was found to be a prerequisite for a two metal ion catalysis (Steitz & Steitz, 1993).   
This whole interplay of RNA-RNA interactions described above between DV and other 
distinct parts of the intron, aligns the two catalytic Mg2+ ions in the required conformation 
as well as it brings all elements needed for catalysis in proximity to each other, 
demonstrating that the entire group II intron structure is required to induce a catalytic 
conformation in DV (Toor et al, 2008a). 
 
Figure 1.12: Close up view on the catalytic center of the group IIC intron from O. iheyensis 
The catalytic center is shown in a surface (left) as well as in a ribbon representation (right). Important 
interactions of DV (red) are indicated in the figure. Active site Mg2+ ions are shown as grey spheres. This 






DV is highly conserved throughout higher organisms and its basic structural features even 
show a considerable similarity to those of the spliceosomal U6 snRNA ((Keating et al, 
2010) see also Figure 1.13). Like DV the U6 snRNA adopts a stem loop structure 
containing a bulge loop coordinating a Mg2+ ion essential for catalysis (Yean et al, 2000). 
This bulge is also separated exactly by 5 bases from the catalytic triad and the triad was 
shown to be involved in binding a second catalytic Mg2+ ion. The function of the 
conserved J2/3 which contacts the lower stem of DV apparently seems to be analogous to 
the invariant ACAGAGA box motif of U6 snRNA which was shown to interact with 
nucleotides close to the bottom of the U6-ISL (Madhani & Guthrie, 1994b). Other results 
obtained through phosphorothioate substitution experiments show that sulphur 
substitutions in DV give the same effects on group II splicing as substitutions at the 
corresponding positions in U6 snRNA on pre-mRNA splicing and therefore also suggest 
similarities between the two splicing machineries (Gordon & Piccirilli, 2001). It was even 
 
Figure 1.13: Comparison between DV of group II introns and the spliceosomal U6-ISL 
Secondary structures of DV (left) and the U6-ISL (right). Tertiary interactions (indicated in red for DV) 
are observed crystallographically for the O. iheyensis intron. Possible analogous interactions are also 





demonstrated that within the minor spliceosome, DV is able to replace the U6atac snRNA, 
thereby providing functional evidence for a close relation between DV and the U6-ISL 
(Shukla & Padgett, 2002). Since it seems to be the major purpose of DI to arrange DV in a 
catalytically active conformation, the question arises whether within the spliceosome 
similar mechanisms exist that might perform an analogous function for the structure of the 
U6-ISL. Some nuclear introns are of remarkable length and probably can fold into 
complex tertiary structures but due to the fact that they show a high degree of variability, it 
is not very likely that they play a major role in the formation of the catalytic core of the 
spliceosome. More obvious would be an interaction of either protein factors and/or other 
snRNAs with the U6-ISL. Prp8 for example, a major scaffolding protein of the 
spliceosome, which contacts all of the chemically reactive sites of the pre-mRNA intron, 
would be an ideal candidate for this task (Grainger & Beggs, 2005). It might also be that 
proteins of the NTC are either directly involved in specifying new RNA interactions 
during splicing, or they achieve this indirectly, by recruiting NTC-related proteins which 
interact with the spliceosomal RNA network. Consistent with the latter, several NTC-
related proteins possess putative RNA-binding domains or have been shown to display 
strong genetic interactions with mutations in the catalytic RNA interaction network (Hogg 







1.10 Aim of this study 
 
One of the most fascinating design principles of the spliceosome is that by stepwise 
recruitment of the snRNPs it assembles initially into a multi-megadalton ribonucleoprotein 
(RNP) complex, so called B complex, which contains all the snRNPs and additional non-
snRNP splicing factors, but which does not have yet a catalytic site. Mass spectrometry of 
the yeast spliceosomes has indicated that at least 90 proteins associate with spliceosomes 
assembled in vitro. Indeed, unlike group II self-splicing introns, nuclear pre-mRNA 
introns and the spliceosomal snRNAs do not self assemble into a catalytically active 
structure in the absence of spliceosomal proteins. The formation of the active catalytic 
center of the spliceosome involves a series of structural rearrangements which are mainly 
driven by RNA-dependent ATPases/helicases and which are accompanied by several 
changes in RNA-RNA base pairing interactions (Staley & Guthrie, 1998).  
The question of the nature of the spliceosomal catalytic center and how it is generated 
during catalytic activation of the B complex is poorly understood and one of the most 
interesting issues of spliceosomal research. Not only the chemical pathway of nuclear pre-
mRNA splicing is identical to that of the self-splicing group II introns but also several 
critical and highly conserved intermolecular structures formed by the pre-mRNA and the 
U6 and U2 snRNAs at the heart of the spliceosome are similar to intramolecular structures 
formed by self-splicing group II introns, supporting the idea that pre-mRNA splicing is 
essentially catalyzed by RNA with U6 and U2 playing key roles (Wachtel & Manley, 
2009). A recent high resolution crystal structure gave remarkable insight into the 
organization of the catalytic core of a group IIC self splicing intron (Toor et al, 2008a). Of 
the six domains of group II introns, domain 5 (DV), shares structural and sequence 
similarities with the essential and conserved U6-ISL. Surprisingly, the structure observed 
for DV in the context of the intact group IIC introns, differs greatly from the conformation 
of this domain when studied in isolation. Within the intact intron the two stems of DV are 
bended at an angle of approximately 45°, a conformation not observed if DV was 
examined in isolation. Responsible for this orientation are plenty of tertiary RNA-RNA 
interactions which help to shape the catalytic center of the intron. Since DV and the U6-
ISL share several evolutionary conserved similarities, the question arose which factors in 
the spliceosome might induce a similar conformation of the U6-ISL and thereby help to 





important RNA elements of group II introns, in particular of DI, is found in the 
spliceosomal RNA network. It can therefore be hypothesized that the role of DI and other 
regions of the group II ribozymes is taken over by proteins in the spliceosome. 
The aim of this work was to identify protein factors interacting with U6 snRNA within the 
catalytic center of purified spliceosomes, to map their interaction sites with U6 snRNA 
and to determine their influence in promoting the catalytically active conformation of the 
U6-ISL. Knowing the exact way proteins interact with U6 snRNA at the heart of the 
spliceosome, might give important clues about the structure of the spliceosomal RNA 
network during splicing. We focused on the yeast protein Cwc2 which was recently shown 
to be essential for splicing in vivo and to contain a Zn-finger and an RNA recognition 
motif (RRM). We show that Cwc2 binds in close proximity to highly conserved RNA 
elements of U6 in Bact complexes, including a more direct and defined binding to the U6 
ISL in the B* and C complexes. This likely confers a proper configuration to the U6-ISL 
and the pre-mRNA 5’ splice site, thus, contributing to splicing catalysis. These 
interactions are evolutionarily conserved, as shown by studies with Cwc2's human 
counterpart RBM22, indicating that Cwc2/RBM22-RNA contacts are functionally 
important. A comparison of the RNP network at the core of the spliceosome revealed by 
our studies with the recently determined crystal structure of group II introns, suggests that 
Cwc2 (in yeast) and RBM22 (in human) have evolved to substitute for the network of 
RNA-RNA interaction that bring the 5’ splice site and DV of group II introns (the 
apparent counterpart of the U6 ISL) into a catalytically active conformation and thereby 
assist in catalysis. Thus, these data might provide additional evidence for mechanistic 
similarities between the spliceosome and group II introns and therefore help to shed light 









Materials and methods 
 
2. Materials and methods 
2.1 Materials 
 
2.1.1 Chemicals and media 
 
2-Mercaptoethanol       Roth, Germany 
Acetic acid        Merck, Germany 
Acetone         Merck, Germany 
Agarose, electrophoresis grade      Invitrogen, Netherlands 
Ammoniumperoxodisulfate (APS)     Merck, Germany 
Ampicillin         Sigma-Aldrich, Germany 
Bacto agar         BD, USA 
Bacto yeast extract       BD, USA 
Bacto peptone        BD, USA 
Bradford-assay solution       Bio-Rad, Germany 
Brilliant Blue G-Colloidal concentrate     Sigma-Aldrich, Germany 
Bromphenol blue        Merck, Germany 
D(+)-glucose monohydrate      Merck, Germany 
Dipotassiumhydrogenphosphate      Merck, Germany 
DNA-molecular weight marker      Gibco, New Zealand 
DTT (Dithiothreitol)       Roth, Germany 
EDTA (Disodium salt dihydrate)      Roth, Germany 
Formaldehyde        Merck, Germany 
Formamide        Merck, Germany 
Glycerol         Merck, Germany 
Glycoblue         Ambion, USA 
HEPES (N-2-Hydroxyethylpiperazin-N-2-ethansulfonic acid) Calbiochem, USA 
Imidazole         Merck, Germany 
Lithium acetate        Sigma-Aldrich, Germany 
Maltose         Merck, Germany 
Methanol         Merck, Germany 
Polyethylene glycol (PEG)      Sigma-Aldrich, Germany 
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Ponceau S         Serva, Germany 
Potassium Chloride       Merck, Germany 
Potassiumdihydrogenphosphate      Merck, Germany 
Pre-stained protein-molecular weight marker   Bio-Rad, Germany 
Roti-Phenol-Chloroform-Isoamyl alcohol (PCI)    Roth, Germany 
Rotiphorese Gel 30 solution      Roth, Germany 
Rotiphorese Gel 40 solution      Roth, Germany 
Rotiphorese Gel A and B solution     Roth, Germany 
Silver nitrate        Merck, Germany 
Sodiumdodecylsulfate (SDS)      Serva, Germany 
Sodiumacetate        Merck, Germany 
TEMED (N, N, N’, N’-Tetramethylethylendiamine)   Sigma-Aldrich, Germany 
Tris-(hydroxymethyl)aminomethane (Tris)    Roth, Germany 
Triton X-100        Merck, Germany 
tRNA E. coli        Boehringer, Germany 
Nonidet P-40 (Igepal CA-630)     Sigma-Aldrich, Germany 
Urea         Merck, Germany 
Xylene cyanol FF       Fluka, Switzerland 
 
 
2.1.2 Enzymes and enzyme inhibitors 
 
AMV Reverse Transcriptase     USB, USA 
Aprotinin        Serva, Germany 
Benzamidine       Serva, Germany 
Chymostatin       Serva, Germany 
CompleteTM protease inhibitor tablets EDTA-free  Roche, Germany 
Leupeptin        Serva, Germany 
Pepstatin A       Serva, Germany 
Phenylmethylsulfonylfluoride (PMSF)    Merck, Germany 
Phusion® High-Fidelity DNA Polymerase   New England Biolabs, Germany 
Proteinase K       Sigma-Aldrich, Germany 
30 
 
Materials and methods 
 
Recombinant RNasin® Ribonuclease Inhibitor   Promega, USA 
Restriction Enzymes      New England Biolabs, Germany 
RNasin (RNase inhibitor; 40 U/μl)    Promega, USA 
RQ DNase I (1 U/μl)      Promega, USA 
SP6 RNA polymerase      New England Biolabs, Germany 
T4 polynucleotide kinase      New England Biolabs, Germany 
T7 RNA polymerase     dept.  Lührmann 
Taq DNA polymerase      Promega, USA 





Nucleoside-5´-triphosphate (ATP, CTP, GTP, UTP 100 mM each):  
Pharmacia, Germany 
 
Deoxynucleoside-5´-triphosphate Mix (dATP, dCTP, dGTP, dTTP 10 mM each):   
New England Biolabs, Germany 
 
Dideoxynucleoside-5’-triphosphate (ddATP, ddCTP, ddGTP, ddTTP mM each): 
Pharmacia, Germany 
 




2.1.4 DNA oligonucleotides and plasmids 
 
DNA oligonucleotides: 
Name  sequence (5’ to 3’)    description 
yU6 94-112 AAAACGAAATAAATCTCTT   complementary to nts 94-    
112 of U6 snRNA 
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yAct 269-254 GCAATTGGGACCGTGC    complementary to nts 254- 
269 of M3Act pre-mRNA 
Cwc2-TAP_for TTGGTAAGCTTGGTGGTCCCTTG oligo used for c-terminal  
 CTCGATTACCTCTCCTCTGATGA  TAP-tagging of Cwc2 
GGATTCCATGGAAAAGAGAAGA 
TG 
Cwc2-TAP_rev GGGAATGTTAATGGCAGATACTT  oligo used for c-terminal 
AGAATTTGGTGGAAACGATTTTC  TAP-tagging of Cwc2 
TTCTTACGACTCACTATAGGG 
Sp6_for  ATTTAGGTGACACTATAG   used for the generation of  
template DNA for in vitro  
transcription 
Act_rev  GGAATTCCCCTTCATCACCAA   used for the generation of  
template DNA for in vitro  
transcription 
Act+13+24  GATGGTGCAAGC    used for RNase H directed  
cleavage of M3Act pre- 




Name   description 
pUC18_T7_M3Act_wt template for in vitro transcription, generated by Dr. Thomas 
Ohrt 
pUC18_T7_M3Act_∆6  template for in vitro transcription, generated by Dr. Thomas 
Ohrt 
pUC18_T7_yU6  template for in vitro transcription, provided by Dr. Patrizia 
Fabrizio (Fabrizio et al, 1989) 
pMal_MS2-MBP  expression of MS2-MBP fusion protein, provided by Robin 
Reed and Josep Vilardell 
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2.1.5 Yeast and bacterial strains 
 
Yeast strains: 
SC1887 (MATα; ade2; arg4; leu2-3, 112; trp1-289; ura3-52; CWC2::TAP-K.I.URA3 
C-terminus); purchased from Euroscarf (Frankfurt am Main). 
SC0546  MATa; ade2; arg4; leu2-3; 112; trp1-289; ura3-52; ECM2::TAP-K.I.URA3  
C-terminus; purchased from Euroscarf (Frankfurt am Main). 
 
SC1215  MATa; ade2; arg4; leu2-3; 112; trp1-289; ura3-52; YJU2::TAP-K.I.URA3    
C-terminus; purchased from Euroscarf (Frankfurt am Main). 
 
YRK1  MATa, trp1Δ1; his3Δ; ura3-52; lys2-801; ade2-101; SNU114::TAP-K.I.TRP1 
C-terminus (Häcker et al., 2008). 
 
YRK5  MATa, trp1Δ1; his3Δ; ura3-52; lys2-801; ade2-101; PRP8::TAP-K.I.TRP1   
C-terminus (Häcker et al., 2008). 
 
YNR1  MATa; prp2-1; ade2; his3; lys2-801; ura3; CWC2::TAP-K.I.URA3                
C-terminus (This study). 
 
3.2.AID/  MATa; prp2-1; ade2; his3; lys2-801; ura3, carrying a G360D 




BL21-CodonPlus(DE3)-RIL cells, F- ompThsdSB (rB- mB-) gal dcm lacY1, pRARE22 
(CMR) pAR5615 (APR) Novagen, USA 
 
DH5α cells, F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, 
mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 
 
 
2.1.6 Commercial kits 
 
ECL western blot detection kit   GE Healthcare, UK 
Prime It II random primer labeling kit   Stratagene, USA 
Qiagen gel extraction kit     Qiagen, Germany 
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Qiagen plasmid preparation kit   Qiagen, Germany 
 
 
2.1.7 Chromatography materials and consumables 
 
Amylose resin     New England Biolabs, Germany 
Calmodulin Sepharose 4B    GE Healthcare, UK 
Cassettes for film exposure    Kodak, USA 
Concentrator     Millipore, USA 
Dialyses membranes MWCO 6000-8000 Da  SpektraPor, USA 
Heparin SepharoseTM 6 Fast Flow   GE Healthcare, UK 
HisTrap™ FF crude columns    GE Healthcare, UK 
IgG Sepharose 6 Fast Flow    GE Healthcare, UK 
Ni-NTA agarose      Qiagen, Germany 
Nylon membrane Hybond XL    GE Healthcare, UK 
Parafilm       Roth, Germany 
Poly-Prep columns     Bio-Rad, USA 
ProbeQuantTM G-50 micro columns   GE Healthcare, UK 
ProbeQuantTM G-25 micro columns   GE Healthcare, UK 
Protein A-Sepharose CL 4B   GE Healthcare, UK 
Protran Nitrocellulose membrane   Schleicher & Schüll, Germany 
Slide-A-Lyzer dialysis units (MWCO 6 kDa)  Pierce, USA 
Sterile filters 0.2 μm or 0.45 μm    Sarstedt, Germany 
Superdex 75 16/60 column    GE Healthcare, UK 
Whatman 3MM Paper     Whatman Paper, UK 
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2.1.8 Common buffers 
 
Media, buffers, and solutions were prepared with deionized water (Millipore) and 
autoclaved if necessary (121 °C, 20 min, 1 bar). Solutions with heat-labile components 
were filter sterilized (0.22 μm).  
 
5x DNA loading dye    30% glycerol 
5 mM EDTA, pH 8.0 
0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol 
 
4x Separating gel buffer    1.5 M Tris 
0.4% (w/v) SDS 
adjust to pH 8.8 
 
4x Stacking gel buffer    0.5 M Tris 
0.4% (w/v) SDS 
adjust pH to 6.8 
 
10x TBE      0.89 M Tris 
0.89 M boric acid 
25 mM EDTA pH 8.0 
 
Protein loading dye    75 mM Tris-HCl, pH 6.8 
1.25 mM EDTA, pH 8.0 
20% (v/v) glycerol 
2.5% (w/v) SDS 
0.125% (w/v) bromophenol blue 
50 mM DTT 
 
RNA loading dye     80% formamide 
1 mM EDTA pH 8.0 
0.05% (w/v) bromophenol blue 
0.05% (w/v) xylene cyanol 
 
Slab 4 Buffer     50 mM Tris 
105 mM glycine 
0.1% (w/v) SDS 
 
SDS-PAGE Running buffer  25 mM Tris-HCl, pH 6.8 
192 mM glycine 
1% (w/v) SDS 
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10x TBS      200 mM Tris 
1.37 M NaCl 
adjust to pH 7.6 
 
Western blotting buffer    1.5 L Slab4 Buffer 
0.6 L methanol 
0.9 L ddH2O 
 
 
2.1.9 Machines and working equipment 
 
ÄKTA Prime      GE Healthcare, UK 
ÄKTA Explorer      GE Healthcare, UK 
Autoclaves      H+P Labortechnik, Germany 
Biofuge fresco      Kendro, USA 
Biofuge pico      Kendro, USA 
DNA Thermal Cycler     Hybaid Omni Gene, UK 
Gel documentation unit     Bio-Rad, USA 
Gelelectrophoresis apparatus    in-house 
Geldryer Model 583     Bio-Rad, USA 
Gradient Master      BioComp Instruments, Canada 
‘head-over-tail’      Rotor Cole-Parmer, USA 
Heating blocks      Eppendorf, Germany 
Hybridization oven     Hybaid Biometra, UK 
Megafuge 1.0R      Kendro, USA 
Milli-Q-water supply apparatus    Millipore, USA 
Nanodrop       Thermofisher, Germany 
pH-Meter       Mettler Toledo, Switzerland 
Phosphorimager Typhoon 8600    Amersham Pharmacia, Germany 
Power supply EPS 2A 2000    Hoefer Pharmacia Biotech, USA 
Power supply EPS 3501/XL    Amersham Pharmacia, Germany 
Liquid Scintillation Analyzer Tri-Carb 2100 T  Packard, USA 
Sorvall SLC-6000 rotor     Kendro, USA 
Sorvall SS-34 Rotor     Kendro, USA 
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Sorvall TH660 Rotor     Kendro, USA 
Sorvall T865 Rotor     Kendro, USA 
Sorvall T647.5 Rotor     Kendro, USA 
Speed Vac Concentrator 5301    Eppendorf, Germany 
Spectrophotometer Ultrospec 3000 pro   Amersham Pharmacia, Germany 
Surespin 630 rotor     Thermo Fisher Scientific, USA 
Tabletop centrifuges     Heraeus, Germany 
Trans-Blot Cell      Bio-Rad, USA 
Ultracentrifuge Evolution    Kendro, USA 
UV lamps (254 nm)    Bachofer, Reutlingen 
Vortex       Janke & Kunkel, Germany 
X-ray film developer X-Omat 2000   Kodak, USA 
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1 OD260 equals   50 µg/ml dsDNA  pure DNA OD260 /OD280 = 1.8 
   40µg/ml  ssDNA 
   33 µg/ml ssRNA  pure RNA OD260 /OD280 = 2.0 
 
Table 2.1: Empirical standard values used for the concentration determination of nucleic acids 
2.2 Methods 
 
2.2.1 General molecular biology methods 
 
2.2.1.1 Concentration determination of nucleic acids  
 
The concentration determination of RNA or DNA is based on the absorption maximum of the 
aromatic ring system of nucleic acids at a wavelength of 260 nm. The concentration and 
purity of nucleic acids was estimated using the empirical standard values shown in  
Table 2.1. The ratio between OD260 and OD280 allows to assess contaminations with proteins 
or phenol. 
2.2.1.2 Purification and manipulation of DNA  
 
Plasmid DNA was obtained from E. coli cells using QIAGEN Plasmid Purification Kits 
according to the manufacturer’s instructions. QIAGEN plasmid purification protocols are 
based on a modified alkaline lysis procedure, followed by binding of plasmid DNA to 
QIAGEN Anion-Exchange Resin under appropriate low-salt and pH conditions.  
 
Restriction endonucleases were obtained from New England Biolabs (NEB) and the reactions 
were performed according to the manufacturer’s instructions. Generally 1-10 units of enzyme 
were used to cut 1µg of DNA within 1h under the recommended conditions. 
 
DNA fragments were analyzed and purified by agarose gel electrophoresis. Typically, the 
gels contained 1% (w/v) agarose, depending on the size of the DNA fragment. The samples 
were dissolved in DNA loading dye and after separation the nucleic acids were visualized via 
ethidium bromide (0.4 µg/ml gel in 1xTBE) staining and subsequent highlighting with UV 
light.    
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2.2.1.3 Polymerase chain reaction  
 
The polymerase chain reaction (PCR) was used to amplify DNA fragments either for analytic 
(e.g. “colony PCR”) or preparative purposes (e.g. transcription templates). A typical reaction 
mixture contained 0.4 ng/µl of template, 0.2 mM of each dNTP, 0.6 µM of each primer, the 
appropriate reaction buffer and the enzyme. Different kinds of polymerases (Taq-, Pfu- or 
Phusion-polymerase) were used depending on the purpose of the application.  
 
A typical setup for a PCR included the following steps: 
 
1. 94°C 5 min  initial denaturation 
2. 94°C 1 min  cycle denaturation 
3. 52°C 1 min  primer annealing 
4. 72°C 1 min  elongation  steps 2 to 4 were repeated 35 times 
5. 72°C 10 min  final elongation 
 
2.2.1.4 Transformation of yeast and E. coli 
 
For transformations, chemically competent cells of S.cerevisiae and E. coli were used. 
50 ml cultures of E.coli were grown to an OD600 of 0.3-0.5 and the cell pellet was washed 
twice with an ice cold solution of 50 mM CaCl2. After the addition of glycerol to a final 
concentration of 10% the cells were frozen in liquid nitrogen and stored at -80°C. For 
transformation competent cells were mixed with 50 ng plasmid DNA and incubated on ice for 
30 min, followed by a heat shock at 42°C for 1 min. Subsequently, the cells were incubated 
for 1h at 37°C in LB medium before being transferred to Petri dishes containing a selection 
medium.  
50 ml cultures of S. cerevisiae were grown to an OD600 of 0.6-0.8. The cells were sedimented 
by brief centrifugation at 2500 x g and washed with buffer containing 10 mM Tris, pH 7.5. 
Subsequently, the pellet was resuspended in a buffer containing 10 mM Tris, pH 7.5 and 
100 mM lithium acetate (LiT-buffer) and incubated shaking slowly at RT for 40 min. After a 
brief centrifugation the cells were resuspended in 800 µl LiT-buffer and the designated DNA 
construct (250 ng for plasmids, 40 µg for PCR constructs) was mixed with 100 µl of cell 
suspension. As a carrier, salmon sperm DNA (1 mg/ml final concentration) was used and a 
solution of PEG 3350 (0.5 g PEG/ml LiT final concentration) was added. A heat shock 
treatment was performed for 5 min at 42°C before the cells were transferred to YPD medium 
and incubated at 37°C (or 25°C if the strain was temperature sensitive) for 1h. Petri dishes 
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containing a selection medium were used to select for successful transformants. Positive 
clones were checked for the correct integration of the construct via colony PCR. 
 
2.2.1.5 Phenol-chloroform-isoamylalcohol (PCI) extraction and ethanol precipitation 
 
The PCI extraction is used to separate nucleic acids from proteins. Phenol and chloroform 
denature proteins and keep them in the organic phase, while nucleic acids stay in the aqueous 
phase. 
Samples were thoroughly mixed with an equal volume of PCI (phenol/ chloroform/ 
isoamylalcohol, pH 7.5-8.0 in the ratio 25:24:1, commercially available from Roth). Phase 
separation was accelerated by centrifugation at 16000 xg for 5 min. The aqueous phase was 
transferred into a new tube and nucleic acids were precipitated by adding 3 volumes of 
absolute ethanol, 0.1 volume of 3M sodium acetate pH 5.3 and, in case of nucleic acid 
concentrations below 200 ng/µl, 10 µg/ml Glycoblue (Ambion) was added as a carrier. 
Proteins were precipitated from the organic phase by adding 5 volumes of absolute ethanol or 
acetone. Both, RNA and protein samples were kept at -20°C for at least 30 min. The 
precipitates were sedimented by centrifugation at 16000 x g for 20 min. The pellet was 
washed with 70% ethanol (v/v), subsequently dried and resuspended in the desired solution. 
   
2.2.1.6 Denaturing polyacrylamide gel electrophoresis of RNA 
 
Denaturing polyacrylamide gel electrophoresis was mainly used to separate RNA species up 
to 1500 bp in size. The gels contained 8M urea as denaturing agent and were used with 
acrylamide concentrations between 5% and 10%.  The acrylamide polymerization was 
initiated by adding ammonium persulfate and TEMED. RNA samples were resuspended in 
RNA loading dye and denatured at 70°C for 3 min prior to gel loading. The electrophoresis 
was performed in 1x TBE buffer at a constant voltage. To allow a better separation of the 
splicing products and intermediates, an optimized ratio of acrylamide to bisacrylamide (29:1) 
was used. RNAs were visualized either by silver staining or autoradiography. In case of 
preparative separations e.g. electrophoresis of in vitro transcriptions, UV highlighting was 
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RNA Gel solutions (per 20 ml) 
8 M (w/v) Urea 
5 % to 10 % acrylamide (either Rotiphorese Gel 40 solution or a 29:1 mixture of Rotiphorese 
Gel A and B) 
2 ml 10 x TBE 
100 μl 10 % (w/v) APS & 10 μl TEMED 
 
2.2.1.7 Silver staining of RNA gels  
 
Silver staining of RNA gels was essentially performed as described by (Merril et al, 1981). 
First, the gel was fixed in a solution of 40% methanol and 10% acetic acid for at least 30 min 
or overnight. The gel was then washed twice with a solution of 10% ethanol and 5% acetic 
acid for 15 min. Afterwards, it was briefly rinsed with ddH2O and subsequently stained with 
a solution of 12 mM AgNO3 for 30 min. The stained gel was briefly rinsed with ddH2O again 
and then incubated with the developing solution (0.28 M Na2CO3, 0.0185% formaldehyde) 
until RNA bands became visible. The developing reaction was stopped by the addition of 5% 
acetic acid.    
 
2.2.1.8 Northern blot analysis  
 
Northern blotting was used to detect specific RNAs, using radioactively labeled DNA 
oligomers complementary to the respective RNA.  
RNA samples were separated using denaturing polyacrylamide gel electrophoresis (see 
2.2.1.6) and subsequently transferred to a nylon membrane via a semidry blotting procedure. 







[%] [bases] [bases] 
   5 130 35 
6 106 29 
8 76 26 
10 55 12 
20 28 8 
 
Table 2.2: Migration behavior of marker dyes in denaturing polyacrylamide gels 
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RNAs were crosslinked to the membrane via UV irradiation with 1200 µJoule x100. Before 
adding the probes, the membrane was incubated with pre-hybridization buffer (see Table 2.3) 
at 42°C for 2h. The pre-hybridization buffer was exchanged with fresh hybridization buffer 
containing the radioactive probes, and the hybridization was carried out for 24-48h at 42°C.  
 
 
Pre-/ Hybridization Buffer     20 x SSC 
25 mM Na3PO4 pH 6.5      300 mM Na-Citrate 
6 x SSC       3 M NaCl 
5 x Deinhardt’s solution 
0.5 % (w/v) SDS      100 x Deinhardt’s solution 
50 % (v/v) Deionized formamide     2 % (w/v) Polyvenylpyrolodase 
0.1 mg/ml Salmon sperm DNA (5 min denat.)   2 % (w/v) BSA 
       2 % (w/v) Ficoll 400 
 
Wash Buffer 1      Wash Buffer 2  
2 x SSC       2 x SSC 
0.5 % (w/v) SDS      0.1 % (w/v) SDS 
 
Table 2.3: Solutions for Northern blotting 
 
After hybridization, the membrane was washed twice at RT for 5 min with wash buffer 1 and 
twice with wash buffer 2. A third wash step with wash buffer 2 was performed for 30 min at 
50°C.  The radioactive probes were visualized via autoradiography. 
The radioactive probes were generated using the Prime It II random primer labeling kit 
according to the manufacturer’s instructions. 
 
2.2.1.9 TAP tagging of yeast cells  
 
Due to the lack of antibodies against the Cwc2 protein, it was tagged within the Prp2-1 
background strain, to be able to immunoprecipitate Cwc2 from purified B*-complexes. 
To fuse a TAP-tag to the C-terminus of Cwc2, a construct carrying the TAP-tag sequence and 
a selection marker was generated via PCR (2.2.1.3). The primers for this reaction were 
designed to overlap with regions of the yeast chromosome, flanking the end of the CWC2 
gene without the stop codon. In this way a homologous recombination allowed the construct 
to be integrated into the yeast genome in frame, resulting in a stable yeast strain expressing a 
tagged Cwc2 protein.  
The primers used for this PCR were named Cwc2-TAP_for and Cwc2-TAP_rev and as PCR 
template the plasmid pBS1539 (Puig et al, 2001) was used (see 2.1.4).  
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The construct was transformed as described in 2.2.1.4 and the correct integration was 
checked via PCR. Western blot analysis (2.2.2.5) demonstrated a stable expression of Cwc2-
TAP in the yeast Prp2-1 background. 
 
2.2.1.10 In vitro transcription  
 
In vitro transcriptions were carried out using linearized plasmid DNA or DNA fragments 
generated by PCR as templates. Depending on the type of the promoter, either Sp6 or T7 
RNA polymerases were used during the reaction. The compositions of typical reaction 
mixtures are shown below.  
 
“hot” transcription 
Template   0.1 µg /µl 
RNA polymerase buffer (NEB) 1x    
rNTPs     A,C+G [0.5 mM];  U [0.1 mM] 
RNasin (Promega)  2 U/µl   
[α -32P] UTP (3000 Ci/mmol) 1 µl/4 µl reaction     
RNA polymerase  (Sp6/T7) 2 U/µl     
 
“cold” transcription      5x selfmade transcription buffer 
Template   0.05-0.1 µg/µl   200 mM  Tris pH 8.0 
Selfmade transcription buffer 1x    150 mM  MgCl2 
rNTPs     2.5 mM each   10 mM   Spermidine 
RNasin (Promega)  2 U/µl    50 mM   DTT 
Pyrophosphatase (ΝΕΒ)  0.02 U/µl    
RNA polymerase (Sp6/T7) 2 U/µl     
 
The transcription reactions were incubated at 37°C for 2h and subsequently purified by gel 
electrophoresis (2.2.1.6). Therefore, the designated RNA bands were cut from the gel and 
were eluted overnight at 4°C with RNA elution buffer (500 mM NaOAc pH 5.0, 1 mM 
EDTA pH 8.0, 2.5% phenol/chloroform/isoamylalcohol, pH 7.5-8.0, 25:24:1 from Roth). The 
next day, the gel pieces were separated from the elution buffer and the RNA was precipitated 
using 3 volumes of absolute ethanol. The pellet was resuspended in ddH2O and the 
concentration of the “cold” RNA was determined by UV spectroscopy (2.2.1.1), while the 
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Age of 32P is in weeks; SA 32P = specific activity of 32P, usually 3μCi/pmol;  
# of Us = number of U residues per transcript. 
 
2.2.1.11 Radioactive 5’-end labeling of oligonucleotides 
 
To label DNA oligonucleotides at their 5’-end, the T4 polynucleotide kinase (T4 PNK) was 
used which transfers the γ-phosphate of a nucleotide to the free 5’-hydroxy group of a DNA 
oligonucleotide. The composition of a typical reaction mixture is shown below: 
 
Reaction mix: 
DNA oligomer   1 pmol/µl 
PNK buffer (NEB)  1x 
[γ-32P] ATP (6000 Ci/mmol) 6 µl/10 µl reaction 
T4 PNK  (NEB)   0.1 U/µl 
 
The reaction was incubated for 1h at 37°C. Subsequently, the reaction volume was adjusted 
to 50 µl and the DNA oligomers were separated from unincorporated free nucleotides using 
G-25 or G-50 spin columns (Amersham). The samples were PCI extracted and ethanol 
precipitated (2.2.1.5).  
 
 
2.2.2 Protein-biochemistry standard methods  
 
2.2.2.1 Concentration determination of proteins  
 
To determine the concentration of proteins mainly the Bradford protein assay was used. This 
method involves the binding of Coomassie Brilliant Blue G-250 dye to proteins (Valadkhan 
& Jaladat, 2010). The dye exists in three forms: cationic (red), neutral (green), and anionic 
(blue). Under acidic conditions, the dye is predominantly in the cationic form with an 
absorption maximum at 470 nm. When the dye binds to protein, it is converted to the blue 
form and the absorption maximum shifts to 595 nm. Using a protein standard, it is possible to 
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determine the concentration of a protein solution. During this work the Bradford protein 
assay kit from Biorad was used, according to the manufacturer’s instructions.  
      
2.2.2.2 Denaturing Polyacrylamide Gel Electrophoresis (PAGE)  
 
To analyze proteins via denaturing PAGE either pre-casted NuPAGE® Bis-Tris gels (4-12%) 
or self-casted polyacrylamide gels were used according to the procedure established by 
Laemmli (1970). Commercial gels were used according to the manufacturer’s instructions. 
For self casted gels typical gel compositions are listed below: 
 
stacking gel      8% separating gel 
4x stacking gel buffer (2.1.8) 375 µl   4x separating gel buffer (2.1.8) 1250 µl 
Rotiphorese Gel 30  250.5 µl   Rotiphorese Gel 30  1332.5 µl 
H2O    874.5 µl   H2O    2417.5 µl 
APS    10 µl   APS    16.75 µl  
TEMED    1 µl    TEMED    16.75 µl  
  
Protein samples were dissolved in protein loading dye and heated up to 95°C for 5 min prior 
to loading. Electrophoresis was typically performed at 150-200V for 45 min using Biorad 
mini gel systems. The gels were stained either with Coomassie Brilliant Blue or with silver.
  
2.2.2.3 Coomassie staining of protein gels  
 
Coomassie Brilliant Blue R-250 is a triphenylmethane dye forming strong non covalent 
complexes with proteins. Coomassie staining of protein gels was essentially performed as 
described in (Sambrook et al, 1989).  
Protein gels were incubated in Coomassie staining solution for 5-15 min, the staining solution 
was removed and the gel was treated with destaining solution until protein bands became 
clearly visible. To stop the destaining the solution was changed with 5% (v/v) acetic acid. 
 
Coomassie staining solution:    Destaining solution:  
50% (v/v) Methanol      50% (v/v) Methanol  
10% (v/v) Acetic acid      10% (v/v) Acetic acid  
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2.2.2.4 Silver Staining of Protein Gels 
 
Silver staining of protein gels was performed according to Blum (1987). First, the gel was 
fixed in a solution of 50% (v/v) Methanol/ 12% (v/v) acetic acid for at least 30 min or 
overnight. Subsequently, the gel was washed twice with 50% (v/v) ethanol and once with 
30% (v/v) ethanol for 20 min each. The gel was then treated with a solution of 0.8 mM 
Na2S2O3 for 60 s and briefly rinsed with water. Afterwards, the gel was stained with a 
solution of 12 mM AgNO3/ 0.026 % formaldehyde for 20 min. The staining solution was 
removed and the gel was rinsed with water, before adding the developing solution (56 mM 
Na2CO3, 0.0185% formaldehyde, 16 μM Na2S2O3). To stop developing, the gel was 
transferred in a solution of 50% (v/v) Methanol/ 12% (v/v) acetic acid.  
 
2.2.2.5 Western blot analysis  
 
For western blot analysis, proteins were transferred to a nitrocellulose membrane (Protan 
BA83 nitrocellulose, 0.2 µm by Schleicher & Schuell) by a wet blot procedure. A Biorad 
Mini Trans-Blot cell was used according to the manufacturer’s instructions. The transfer 
usually was performed at 250 mA for 2h and a Slab4, methanol, H2O mixture (in a ratio of 
5:2:3) was used as transfer buffer. After the blot, the membrane was stained with Ponceau S 
to check for a proper transfer. The stain was removed by washing with a TBS-Tween solution 
(1x TBS, 0.1% Tween) 2-3 times for 5 min each. Next, the membrane was incubated for 1h at 
RT in a TBS-Tween solution containing 5% fat free milk powder, to block unspecific 
interactions between the antibody and the membrane. The antibody was then added to the 
blocking solution in the designated dilution and incubated at RT for 1h. Afterwards, the 
membrane was briefly rinsed with TBS-Tween twice, and then 2 times with TBS-Tween for 
20 min each. If a second antibody was needed, it was added after this step and the previous 
steps were repeated. However, in this work mostly the PAP complex (anti-peroxidase anti-
peroxidase complex) was used to detect the TAP-tag, and therefore no secondary antibody 
was required.  
The PAP complex bound to the TAP-tag was visualized on the membrane using the ECL 
western blot detection kit (GE Healthcare, UK). The principle of the detection kit is based on 
a chemiluminescence reaction. The peroxidase of the PAP complex catalyses the oxidation of 
luminol in the presence of hydrogen peroxide, resulting in the emission of light, which can be 
detected by a film or camera.  
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2.2.2.6 Purification of recombinant proteins  
 
In the course of this work different proteins, recombinantly expressed in E.coli and 
subsequently purified were used. The cloning and some of the purifications were done by Dr. 
Jana Schmitzová, MPI-BPC Göttingen. 
The genes, coding for the proteins to be expressed were cloned as described in Warkocki et al 
(2009). Full length CWC2, PRP2 and CWC25, the N-terminally truncated form of SPP2 (aa 
36-185) and a truncation of CWC2 lacking the C-terminus (Cwc2∆CTD, amino acids 1-234) 
were amplified by standard PCR and ligated into the following vectors: PRP2, SPP2 into 
pET21a (Novagen) and CWC2, CWC2∆CTD into pET22b(+) resulting in fusion proteins with 
a C-terminal hexahistidine tag. CWC25 was ligated into pETM11, resulting in an N-terminal 
hexahistidine tagged fusion protein. The constructs were sequenced and transformed into E. 
coli BL21 cells (Novagen) carrying the Rosetta plasmid (Novagen). E. coli cultures were 
grown in 2xYT medium or in autoinducing medium containing antibiotics for selection of the 
plasmids (Studier, 2005). In the case of 2xYT medium, expression was induced by adding 
0.6 mM IPTG. After 20 h (or 48 h in the case of auto-inducing medium) at 17°C, the cells 
were harvested, the pellets were washed and stored at -80°C. 
For cell lysis, the pellet was resuspended in 5 ml lysis buffer per gram of cells and processed 
with a microfluidiser (Microfluidics) at 80 psi for 2-3 times. The lysate was separated from 
cell debris by centrifugation (12000 x g, 4°C, 40 min) and applied to liquid chromatography 
using the ÄKTA system (GE Healthcare). In a first chromatography step His Trap HP FF 
columns (GE Healthcare) were used to selectively purify to His-tagged proteins. The column 
was equilibrated with lysis buffer and after sample loading it was washed with wash buffer 
according to the manufacturer’s instructions. In case the protein interacted strongly with 
RNA an additional washing step with 2M LiCl was included. The sample was eluted using 
elution buffer containing imidazole and eluted proteins were dialyzed against lysis buffer.  
Subsequently, the tags were cleaved by the addition of TEV or Prescission proteases and the 
proteases were removed by affinity chromatography, retaining the proteases and the tag on 
the matrix, while the purified proteins went in the flow-through. Using Centricon 
concentrators (Millipore) the protein samples were concentrated and subsequently processed 
by a gelfiltration. After gelfiltration, the obtained protein solution was pure to 97% judging 
by SDS-PAGE. The sample concentration was determined by Bradford protein assay 
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Lysis buffer for His-tagged proteins    Elution buffer for His-tagged proteins 
20 mM HEPES pH 7.5     20 mM HEPES pH 7.5  
600 mM NaCl      600 mM NaCl  
2 mM β-Mercaptoethanol     2 mM β-Mercaptoethanol 
15% glycerol      15% glycerol  
15 mM Imidazole     250 mM Imidazole   
 
Wash buffer for His-tagged proteins    
20 mM HEPES pH 7.5       
600 mM NaCl/ 2M LiCl        
2 mM β-Mercaptoethanol     
15% glycerol  
15 mM Imidazole 
 
Buffer for gelfiltration of His-tagged proteins 
20 mM HEPES pH 7.5  
200 mM NaCl   






The MS2-MBP fusion protein used for the purification of spliceosomal complexes was 
expressed and subsequently purified from E. coli cells. Cells containing the plasmid encoding 
the MS2-MBP protein were grown to an OD600 = 0.3-0.6 at 37°C in LB medium 
supplemented with the respective antibiotics. To induce the expression, IPTG was added to a 
final concentration of 0.1 mM and the cells were incubated further until they reached an 
OD600 = 2-2.5. The cultures were harvested by centrifugation and the cell pellets were 
subsequently washed with ddH2O. For cell lysis, the pellet was resuspended in 5 ml lysis 
buffer (20 mM Tris-HCl, pH 7.6, 200 mM NaCl, complete EDTA-free protease inhibitors 
from Roche according to the manufactures instructions) per gram of cells and processed with 
a microfluidiser (Microfluidics) at 80 psi for 2-3 times. The lysate was separated from cell 
debris by centrifugation (12000 x g, 4°C, 40 min) and incubated head-over-tail with 500 µl of 
amylose resin per 10 ml of lysate for 2h. Afterwards, the suspension was transferred into a 
Bio-Spin chromatography column (Biorad) and the resin was washed with 10 column 
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volumes (CV) of wash buffer (20 mM HEPES, pH 7.9, 150 mM NaCl, 0.05% NP-40). To 
decrease the salt concentration in view of the next purification step the amylose resin was 
washed with 5 CV of 5 mM Na2HPO4, pH7.0 before the protein was eluted with 5 mM 
Na2HPO4 containing 20 mM maltose. The eluate was loaded onto a heparin agarose column 
equilibrated with 5 mM Na2HPO4, pH7.0. After washing with 10 CV of 5 mM Na2HPO4, 
pH7.0, the MS2-MBP protein was eluted using a higher salt concentration within the elution 
buffer (20 mM HEPES/KOH, pH 7.9, 100 mM KCl, 15% Glycerol, 0.5 mM DTT). The 
protein was shock frozen in liquid nitrogen and stored at -80°C. 
 
 
2.2.3 Cell culture and extract preparation  
 
2.2.3.1 Cultivation of bacteria 
 
E. coli cells were grown in lysogeny broth (LB) medium (Sambrook et al, 1989), 2xYT 
medium or in autoinducing medium (Studier, 2005). The medium was autoclaved for 15 min 
at 121°C. For the selection of antibiotic resistances the medium contained Ampicillin 
(100 µg/ml), Chloramphenicol (30 µg/ml) or Kanamycin (30 µg/ml). Cells were stored for 
long term at -80°C by adding 15% glycerol as a cryopreservative.  
 
2.2.3.2 Cultivation of yeast cells  
 
Yeast cells were grown in Yeast Extract Peptone Dextrose (YPD) medium, either on plates or 
in liquid culture. The medium was autoclaved for 15 min at 121°C and sterile glucose was 
added afterwards to avoid a caramelizing effect of the sugar. 
 
YPD-medium 
2 % (w/v) Bacto peptone 
1 % (w/v) Yeast extract  
2 % (w/v) Glucose (filter sterilized) 
1 % (w/v) Bacto agar in the case of YPD-plates 
 
Usually, a single yeast colony was used to inoculate a liquid pre-culture which was then used 
to inoculate larger amounts of medium in Erlenmeyer flasks or a fermenter. Depending on the 
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phenotype of the strain the cells were cultivated at a temperature between 25-30°C. Cells 
were stored for long term at -80°C by adding 15% glycerol as a cryopreservative.  
 
2.2.3.3 Preparation of yeast whole cell extracts and immunodepletion  
 
The preparation of yeast whole cell extracts for subsequent use during in vitro splicing 
reactions was performed essentially as described by Gottschalk et al (1999). Cells were 
grown to the middle logarithmic phase (OD600= 3-5) and harvested by centrifugation at 5600 
x g for 10 min. The pellet was washed twice with cold H2O and subsequently resuspended in 
cold AGK buffer (20 mM HEPES/KOH pH 7.9, 200 mM KCl, 1.5 mM MgCl2, 8% (v/v) 
glycerol) supplemented with 0.5 mM DTT, 0.5 mM PMSF, 2 mM benzamidine, 1 μM 
leupeptin, 2 μM pepstatin A, 4 μM chymostatin, and 2.6 μM aprotinin. The volume of the 
suspension was measured and the concentration of KCL was adjusted to 200 mM again. To 
obtain yeast beads 2-5 mm in diameter, the cell suspension was dripped into liquid nitrogen, 
using a separating funnel. For cell lysis, these beads were ground in liquid nitrogen at 18000 
rpm using a centrifugal mill (Retsch). The powder formed during the grinding process was 
slowly thawed at RT, and the cell debris were separated from the extract by centrifugation 
(25000 x g, 4°C, 30 min). A second centrifugation step at high speed was used in order to 
clarify the extract (100000 x g, 4°C, 1h). During the centrifugation the extract was separated 
into three phases. The upper phase contained lipids and liposomes, the middle phase was 
clear and the pellet contained ribosomes, DNA and fine cell debris. The middle phase was 
recovered and dialyzed twice against 50-100 volumes of buffer D (20 mM HEPES/KOH pH 
7.9, 50 mM KCl, 0.2 mM EDTA, 0.4 mM MgCl2, 20% (v/v) glycerol, 0.5 mM DTT, 0.5 mM 
PMSF, 2 mM benzamidine) for 1.5h each. After dialysis, the extract was centrifuged at 17000 
x g for 5 min and subsequently frozen in liquid nitrogen. The extract was stored for long term 
at -80°C. 
 
If the extract originated from a strain in which a spliceosomal factor was fused to a TAP-tag, 
it was possible to deplete this factor just before the dialysis step, by incubation of the extract 
with IgG-beads (GE Healthcare). To the recovered middle phase, 0.25 volumes of IgG-beads 
were added and incubated slowly rotating head-over-tail at 4°C for 1.5 hours. By passing the 
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2.2.4 Special methods 
 
2.2.4.1 In vitro splicing reactions  
 
In vitro splicing reactions were performed essentially as described by Fabrizio et al (1989). A 
splicing reaction usually contained 40% total yeast extract, 1x splice cocktail (see below) and 
4000 cpm/µl (~400 pmol/µl) of radioactively labeled Actin WT pre-mRNA. The reactions 
were incubated at 23°C for 0-60 min and aliquots were taken at several time points. The 
reactions were stopped by storing them on ice. Afterwards, Proteinase K digestion was used 
to strip off completely the proteins of the RNA. A typical Proteinase K reaction included the 
sample to be digested, 2% SDS, 300 mM NaCl, 25 mM EDTA and 200 mM Tris-HCl pH 
7.5. The reactions were incubated at 42°C for 30 min and were followed by PCI extraction 
and ethanol precipitation (2.2.1.5). The RNAs were separated by denaturing PAGE and the 
gels were analyzed by autoradiography.  
 
5x splicing cocktail: 
300 mM phosphate buffer, pH 7.3* 
15 % (w/v) PEG 8000 
10 mM ATP 
12.5 mM MgCl2 
10 mM spermidine 
 
*phosphate buffer at pH 7.3 was prepared by mixing solutions of K2HPO4 and KH2PO4 according to Sambrook 
et al (1989). 
 
2.2.4.2 Purification of spliceosomal complexes 
  
The purification of spliceosomal yeast complexes was essentially performed according to 
Fabrizio et al (2009). First, the pre-mRNA substrate was bound to the MS2-MBP fusion 
protein by incubating a 30 times molar excess of MS2-MBP with the designated pre-mRNA 
and 20 mM HEPES-KOH, pH 7.9 on ice for 30 min. Subsequently, the pre-mRNA was 
mixed with 40% extract (2.2.3.3) and 1x splicing cocktail (2.2.4.1) and splicing was carried 
out at 23°C for 50 min. During preparative in vitro splicing reactions the final concentration 
of pre-mRNA usually was 2 nM. After the incubation at 23°C, the splicing reaction was 
chilled on ice and then loaded on top of a 10-30% (v/v) glycerol gradient, containing G150 
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buffer (20 mM HEPES-KOH, pH 7.9; 1.5 mM MgCl2; 150 mM KCl). Sedimentation was 
carried out at 90000 x g at 4°C for 18h. Afterwards, the gradients were fractionated from top 
to bottom and the fractions were analyzed by Cherenkov counting in a scintillation counter. 
The fractions containing the spliceosomal complexes were pooled and loaded on an amylose 
column, equilibrated with G150 buffer beforehand. The column was washed with 10 column 
volumes (CV) of G150 buffer supplemented with 5% glycerol and 0.01% NP40, and 
spliceosomal complexes were eluted using G150 buffer containing 12 mM maltose, 5% 
glycerol and 0.01% NP40. 
After the elution from the amylose column the spliceosomal complexes were used either for 
UV crosslinking/structure probing experiments, for reconstitution of B* or C-complexes, or a 
second gradient centrifugation was carried out as a third step purification.  
 
In case of complex C purification, the splicing reaction was followed by an RNase H 
digestion. For this purpose, a DNA oligo complementary to nts 13-24 of the intron was added 
to the reaction, followed by an additional incubation at 30°C for 10 min. In this way, the 
endogenous RNase H present in the extract digests the RNA intron of early spliceosomal 
complexes whose presence would otherwise complicate the purification.  
 
2.2.4.3 UV-crosslinking of spliceosomal complexes  
 
UV crosslinking was used to characterize sites of direct protein-RNA interactions within 
native spliceosomal complexes. In general, the irradiation of RNP particles results in the 
generation of covalent interactions between proteins and RNA if they are in a favorable 
arrangement (Urlaub et al, 2005). 
UV crosslinking of spliceosomal complexes was essentially performed as described by 
Urlaub et al (2005). Approximately 1–4 pmol of purified yeast complexes were pipetted onto 
pre-cooled 10-well multitest slides and then irradiated for 60 s with UV light at 254 nm on 
ice. To the irradiated and non-irradiated control samples of spliceosomal complexes, SDS 
was added to a final concentration of 1% and incubated for 10 min at 70 °C to destroy all non 
covalent interactions. The samples were chilled at room temperature before the addition of 
Triton X-100 to a final concentration of 5%, then diluted with 5–6 volumes of NET-150 




Materials and methods 
 
2.2.4.4 Immunoprecipitation of protein-RNA crosslinks  
 
To enrich for crosslinks to one specific protein, immunoprecipitation was used. Spliceosomes 
were assembled from extract in which one factor was fused to the TAP tag (Puig et al, 2001). 
The TAP-tag consists of a CBP part separated from a Protein A part by a TEV cleavage site. 
In this work, the strong interaction of Protein A with the Fc fragment of IgGs was used to 
affinity select tagged protein factors. The immunoprecipitation was performed under 
denaturing conditions. In this way, RNAs were co-precipitated with the tagged protein only if 
they were covalently attached to it. 
Protein A or IgG Sepharose (GE Healthcare) resins were washed with NET-150 buffer and 
incubated at 4 °C with UV-crosslinked or non-crosslinked yeast complexes prepared as above 
(2.2.4.3). After washing with NET-150 buffer, beads were incubated with PK-mix (0.5–1 
mg/ml Proteinase K, 50 mM EDTA pH 8.0, 1% SDS) for 20 min at 42 °C followed by PCI 
extraction and ethanol precipitation. The pellet was dried and dissolved in water. 
 
2.2.4.5 Chemical modifications of RNA 
 
In order to analyze the impact of the absence of Cwc2 from the spliceosome on the 
spliceosomal RNA network, different chemicals were used to assess RNA structural features. 
These reagents modify unpaired nucleotides, while base-paired nucleotides or those bound by 
protein remain unmodified.The modification reagents used were dimethylsulfate (DMS; 
Riedel-de Haën), and 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene 
sulfonate (CMCT; Fluka).  
DMS primarily reacts with N7-G, N1-A and N3-C at a neutral pH and therefore only 
modifications at A and C should be detectable by primer extension (Ehresmann et al, 1987), 
since these positions are required for Watson-Crick basepairing (Figure 2.1). CMCT on the 
other hand primarily reacts with N3-U and N1-G at pH 8.0. Thus, with CMCT only 
modifications at U and G should be detectable by primer extension. 
For the modification reactions, 500 fmol of Bact complex were incubated with modification 
reagents in the presence of 10 µg E. coli tRNA, essentially as described by others 
(Ehresmann et al, 1987). In brief, 1 µl DMS was added per 200 µl reaction and incubated at 
20 °C for 8 min. The reaction was stopped by the addition of 50 µl DMS stop buffer (1 M 
Tris-HOAc pH 7.5, 2 M β-mercaptoethanol, 12.5 mM EDTA). CMCT modifications were  
53 
 
Materials and methods 
 
performed at 20 °C for 30 min in the presence of 8 mg of CMCT per 200 µl reaction. To 
recover the RNA, samples were first ethanol-precipitated and then digested with proteinase K 
and PCI-extracted. Following ethanol precipitation, samples were diluted with water and used 
for primer extension analysis. 
 
2.2.4.6 Primer extension analysis  
 
Primer extension analysis was used to detect crosslinks of protein to RNA or modifications of 
RNA by different modifying reagents. The reverse transcriptase cannot read through 
nucleotides whose Watson-Crick base pairing is blocked, either by crosslinked peptide or by 
other means of chemical modification. Therefore, the elongation of the nascent transcript is 
aborted, resulting in a truncated DNA product. Separating the DNA fragments on a 
denaturing gel together with a sequencing reaction, allows the identification of the 
nucleotides whose Watson-Crick base pairing was blocked. 
Oligodeoxynucleotide primers complementary to nts 94–112 of the U6 snRNA and 254–269 
of the M3Act pre-mRNA were labelled with 32P at their 5’ end by T4 polynucleotide kinase 
(2.2.1.11), and ~1 to 2 x 105 cpm of primer was used for one reverse transcription reaction. 
The samples were denatured by heating at 96 °C for 1 min, annealed by cooling to room 
temperature, and reverse-transcribed with 1.5 U of AMV reverse transcriptase (USB) for 
45 min at 43 °C. Sequencing ladders were obtained from U6 RNA and M3Act pre-mRNA 
 
 
Figure 2.1: Watson-Crick basepairing 
DMS primarily modifies N7-G, N1-A and N3-C and CMCT primarily reacts with N3-U and N1-G. 
Picture taken from http://www.lsbu.ac.uk/water/nucleic.html 
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prepared by in vitro transcription (2.2.1.10) under identical conditions, except that 0.05 mM 
dideoxynucleoside triphosphates were included. Reverse transcripts were separated on a 9.6% 
polyacrylamide sequencing gel containing 8.3 M urea and visualized by autoradiography. 
 
2.2.4.7 Mass spectrometry 
 
For Mass spectrometry, proteins recovered from purified spliceosomal complexes (usually 
between 100-400 fmol), were separated by SDS-PAGE using a 4-12% Bis-Tris-HCL (pH 
7.0) NUPAGE polyacrylamide gel (Invitrogen) and stained with Coomassie. Entire lanes 
were cut into 23 slices and proteins were digested in-gel with trypsin and extracted as 
described by described Shevchenko et al (1996). Resulting peptides were analyzed in an LC-
coupled ESI Q-ToF (QToF Ultima, Waters) and/or OrbitrapXL (ThermoFisher Scientific) 
mass spectrometer under standard conditions. Proteins were identified by searching fragment 







As pointed out above, there are many indications for the hypothesis that the mechanism of 
splicing between group II self-splicing introns and the spliceosome might be very similar. 
Especially DV of group II introns shares important evolutionary conserved features with the 
U6-ISL and both of these elements, DV and the U6-ISL are crucial components of the 
catalytic core within their respective splicing machinery. For DV however it was 
demonstrated that it only adopts its active conformation within the huge scaffold of DI where 
plenty of tertiary RNA interactions are required to position and even bend its RNA structure. 
Based on the similarities between DV and the U6-ISL it is assumed that analogous 
mechanisms could be required to position the U6-ISL within the catalytic center of the 
spliceosome. Since introns of nuclear pre-mRNA most likely do not adopt a 3 dimensional 
fold -comparable to the one of group II introns- which could play a role in shaping the 
catalytic core of the spliceosome, most likely spliceosomal factors are needed to position the 
U6-ISL properly. To identify possible interaction partners of U6 snRNA and to characterize 
their role during catalytic activation of the spliceosome a crosslinking approach was applied.  
 
 
3.1 Cwc2 can be crosslinked to U6 RNA and the pre-mRNA in 
activated spliceosomes 
 
To discover spliceosomal factors which might fulfill a function analogous to DI within group 
II introns a crosslinking approach was applied to identify proteins possibly interacting with 
U6 snRNA within purified spliceosomal complexes. 
A prerequisite for these crosslinking experiments was the purification of spliceosomal 
complexes in their native state. The purification procedure was essentially performed as 
described by Fabrizio et al (2009). Spliceosomes were assembled in vitro under splicing 
conditions in the presence of different pre-mRNA substrates containing three RNA stem loop 
structures (MS2 loops), known to interact tightly with a coat protein of the MS2 phage. In 
this way, the pre-mRNA substrates could be bound to a fusion protein consisting of the MS2 







After assembly, the reactions were initially separated on a glycerol gradient in which the 
spliceosomal complexes migrated in the 40S - 45S region, depending on the type of the 
complex. The complex containing fractions were combined and loaded onto an amylose 
matrix for the MS2-MBP affinity chromatography step. The complexes were eluted with 
buffer containing maltose and then used for crosslinking or structure probing experiments. 
To monitor the purity and the functional status of the purified complexes usually a denaturing 
gel electrophoresis of the RNA and protein components was performed. Figure 3.1 shows an 
example of such an analysis for a Bact complex assembled on M3Act∆6 pre-mRNA. The left 
panel represents a protein gel stained with Coomassie Brilliant Blue where the typical protein 
    
  
 
Figure 3.1: Analytics of spliceosomal complexes by gel electrophoresis 
The composition of Bact complexes , purified by glycerol gradient centrifugation and affinity chromatography, 
was analyzed by SDS-PAGE (panel 1) and subsequent staining with Coomassie Brilliant Blue in case of protein 
samples, or by denaturing PAGE and subsequent staining with silver for RNA samples (panel 2). The 
autoradiogram of the RNA silver gel is shown in panel 3. Contaminations, most probably by ribosomal RNAs 





pattern for Bact complexes is clearly visible. The factors above 75 kDa in size were assigned 
by their molecular weight, as determined by mass spectrometry and quoted on the right. 
Almost no contamination with non spliceosomal factors was found, indicating that the 
purification of spliceosomal complexes was close to homogeneity. The RNA composition 
was analyzed by staining the RNAs with silver (panel 2) and shows mainly U2 snRNA, pre-
mRNA, U5L snRNA, U5S snRNA and U6 snRNA. Only minor contaminations of U1 
snRNA and most probably ribosomal RNAs (indicated on the right with asterisks) are visible. 
The autoradiography (panel 3) confirms the identity of the pre-mRNA. All RNAs are intact 
and show almost no degradation, indicating that the spliceosomal complexes are largely 
intact and free from contaminating RNases. 
 
To induce covalent protein-RNA crosslinks purified Bact complexes were exposed to UV light 
at a wavelength of 254 nm for 1 min and subsequently subjected to denaturing conditions in 
 
Figure 3.2: Schematic overview of the crosslinking and immunoprecipitation procedures 
Purified spliceosomal complexes were UV irradiated (1.), disassembled under denaturing conditions (2.) and 
subsequently subjected to immunoprecipitation (3.). Co-precipitated RNA species were extracted (4.) and 





order to disrupt protein-protein and non-covalent RNA–protein interactions (see also Figure 
3.2). Immunoprecipitation was used to assess if RNAs were specifically crosslinked to the 
factor under investigation. The sample was therefore incubated with IgG Sepharose, allowing 
the selective immunoprecipitation of RNA species crosslinked to the protein factor carrying a 
TAP-tag. After extensive washing, the beads were digested with Proteinase K (2.2.4.1) and 
the RNA was PCI extracted and precipitated with ethanol (2.2.1.5). Co-precipitated RNAs 
were identified by Northern blot analysis. 
Proteins used for the crosslinking experiments were chosen on the basis of different 
circumstances. They were either implicated in interactions with U6 snRNA before or they 
belong to the group of proteins joining the spliceosome during the transition from B to Bact 
complex, when almost all other known U6 snRNA interaction partners are released from the 
spliceosome (see also Figure 1.7). Prp8 for example, one of the largest and most highly 
conserved nuclear proteins, occupies a central position in the catalytic core of the 
spliceosome (Grainger & Beggs, 2005), and it has been shown to crosslink not only to U6 
snRNA (Vidal et al, 1999), but also to U5 snRNA within the tri-snRNP (Dix et al, 1998) and 
 
Figure 3.3: Cwc2 crosslinks to yeast U6 snRNA and pre-mRNA within activated spliceosomes.  
 
Northern blot analysis of the RNAs derived from UV-irradiated Bact complexes carrying Cwc2 tagged with 
the TAP tag (lane 4) and after immunoprecipitation of Bact complexes with IgG Sepharose beads (IP, lane 2). 
Lanes 1 and 3 are controls without UV irradiation. RNA was analysed on an 8% polyacrylamide gel and 
visualized by autoradiography. The positions of the snRNAs and M3Act∆6 pre-mRNA are indicated on the 







to multiple regions of the pre-mRNA within spliceosomes (Vijayraghavan et al (1986), 
Whittaker and Beggs (1991), Turner et al (2006)). Snu114, an important spliceosomal 
GTPase which is involved in the regulation of Brr2 could likewise be crosslinked to U5 
snRNA and might also be contacting U6 snRNA (Dix et al, 1998; Frazer et al, 2008). 
Another factor, the NTC related protein Ecm2 has been shown to be involved in the 
formation of U2/U6 helix II during the activation of the spliceosome and contains known 
RNA binding domains (Xu & Friesen, 2001). Also Cwc2 belongs to the group of NTC 
related proteins, contains a zinc finger and an RNA recognition motif (RRM) and it has been 
implicated in U6 snRNA binding under splicing conditions (McGrail et al, 2009).  
Within Bact complexes however, among these factors, only Cwc2 could be crosslinked to U6 
snRNA under the conditions used here (Figure 3.3, note that the 32P-labelled pre-mRNA used 
for complex formation is also visible in the autoradiogram). Upon UV irradiation of purified 
Bact complexes some loss of U6 snRNA was observed, while the other RNA signals remained 
largely unchanged (Figure 3.3, compare lanes 3 and 4). In the absence of UV irradiation, no 
RNA was co-immunoprecipitated together with Cwc2 (lane 1), confirming that all non-
 
 
Figure 3.4: Crosslinking of Prp8, Snu114, Ecm2 and Yju2 to pre-mRNA and snRNAs within affinity-
purified Bact complexes.  
 
Northern blot analysis of the snRNAs derived from UV-irradiated Bact complexes carrying Prp8 or Snu114 or 
Ecm2 or Yju2 tagged with the TAP-tag (lanes 4) and after immunoprecipitation of denatured Bact complexes 
with IgG Sepharose beads (IP, lanes 2). Lanes 1 and 3 are controls without UV irradiation. RNAs were analyzed 
on an 8% polyacrylamide gel and visualized by autoradiography. The positions of the snRNAs and M3ActΔ6 
pre-mRNA are indicated on the right. Prp8 crosslinks to U5 snRNA and to pre-mRNA. Snu114 crosslinks to U5 
snRNA, to the pre-mRNA and also to U2 snRNA. Ecm2 crosslinks to the pre-mRNA, while Yju2 showed no 





covalent RNA-protein interactions were disrupted under the immunoprecipitation conditions 
used. In contrast, upon UV irradiation solely the U6 snRNA and the pre-mRNA were co-
precipitated. The crosslinked U6 snRNA migrated more slowly than non UV irradiated U6 
snRNA, presumably due to a bound residual oligopeptide (digestion fragment) of Cwc2. 
These data indicate that in the purified Bact complex, Cwc2 can be crosslinked specifically 
not only to U6 snRNA but also to the pre-mRNA.  
Figure 3.4 gives an overview of the crosslinks found for the other factors under investigation. 
Prp8, as expected, crosslinked to pre-mRNA and to U5 snRNA, but however, no U6 snRNA 
could be co-precipitated together with Prp8 under these conditions (Prp8, lane 2). Also Ecm2, 
which was suspected to interact with U6 snRNA and/or U2 snRNA, could not be crosslinked 
to neither of them, but nevertheless, unexpectedly precipitated pre-mRNA (Ecm2, lane2), an 
interaction unknown till now. Likewise, the crosslinks of Snu114 to pre-mRNA and U2 
snRNA (Snu114, lane 2) were not reported up to now and are therefore interesting. The 
interaction of Snu114 to U5 however has been described before by Dix et al (1998) and 
therefore, it can be considered, together with the U5 snRNA and pre-mRNA crosslinks of 
Prp8 a proof of concept of the crosslinking procedure. The NTC related factor Yju2 did not 
crosslink to any spliceosomal RNA, indeed demonstrating a very selective crosslinking 
behavior of the five proteins tested here. 
 
 
3.2 Cwc2 interacts with the U6-ISL and a region upstream of the 
U6 ACAGAGA box 
 
To map the crosslinking sites of Cwc2 on U6 snRNA and the pre-mRNA, primer extension 
analysis was performed (Ehresmann et al, 1987). During the reverse transcription of 
crosslinked RNA, the reverse transcriptase cannot read through nucleotides whose Watson-
Crick base pairing is blocked, e.g. by a crosslinked amino acid. Therefore, the elongation of 
the nascent transcript is aborted one nucleotide prior to the crosslink, resulting in a truncated 
DNA product. Separating the DNA fragments on a denaturing gel together with a sequencing 
reaction allows the identification of the nucleotides whose Watson-Crick base pairing was 
blocked. To distinguish between reverse transcriptase stops reflecting a protein crosslink and 
stops caused simply by RNA damage (e.g. UV irradiation induced strand breaking, thymine 






controls (Figure 3.5, Figure 3.6 and Figure 3.9 lanes 10 and 11). Thus, identical stops 
appearing within the in vitro transcribed RNAs and in the input samples, likely would not  
 
 
Figure 3.5: Cwc2 interacts with the U6-ISL and a region upstream of the ACAGAGA box in yeast Bact 
complexes. 
  
Primer-extension analysis of U6 snRNA derived from UV irradiated Bact complexes containing TAP-tagged 
Cwc2, after immunoprecipitation with IgG Sepharose beads (IP, lane 7), or without immunoprecipitation (input, 
lane 9). Lane 11, analysis of UV-irradiated in vitro transcribed U6 snRNA, lanes 6, 8, and 10 are controls 
without UV irradiation. U, C, A, and G are dideoxy sequence markers (‘0’, no ddNTP). Regions corresponding 
to the U6-ACAGAGA and ISL sequences are marked on the left. Reverse transcriptase stops that are due to 







represent protein-RNA crosslinks. However, it cannot be ruled out that a strong signal 
appearing upon UV irradiation of the RNA, masks a weaker signal induced by a protein 
crosslink in the same spot within the RNP sample.  
 
 
Figure 3.6: Cwc2 interacts with the U6-ISL and a region upstream of the ACAGAGA box in yeast B* 
complexes. 
  
Primer-extension analysis of U6 snRNA derived from UV irradiated B* complexes containing TAP-tagged 
Cwc2, after immunoprecipitation with IgG Sepharose beads (IP, lane 7), or without immunoprecipitation 
(input, lane 9). Lane 11, analysis of UV-irradiated in vitro transcribed U6 snRNA, lanes 6, 8, and 10 are 
controls without UV irradiation. U, C, A, and G are dideoxy sequence markers (‘0’, no ddNTP). Regions 
corresponding to the U6-ACAGAGA and ISL sequences are marked on the left. Reverse transcriptase stops 






The input lanes (Figure 3.5, Figure 3.6, Figure 3.7 and Figure 3.9 lanes 9) reflect crosslinks 
found in U6 snRNA or in the pre-mRNA within the respective complex (i.e. Bact, B* or C 
complex). To identify crosslinks specific for Cwc2, RNAs co-precipitated together with 
 
Figure 3.7: Cwc2 interacts with the U6-ISL and a region upstream of the ACAGAGA box in yeast C 
complexes. 
  
Primer-extension analysis of U6 snRNA derived from UV irradiated C complexes containing TAP-tagged Cwc2, 
after immunoprecipitation with IgG Sepharose beads (IP, lane 7), or without immunoprecipitation (input, lane 9). 
Lane 11, analysis of UV-irradiated in vitro transcribed U6 snRNA, lanes 6, 8, and 10 are controls without UV 
irradiation. U, C, A, and G are dideoxy sequence markers (‘0’, no ddNTP). Regions corresponding to the U6-
ACAGAGA and ISL sequences are marked on the left. Reverse transcriptase stops that are due to RNA–protein 






Cwc2 during the immunoprecipitation (see 3.1) were analyzed in parallel (lanes 7). In these 
samples, stops induced by Cwc2 crosslinks should be heavily enriched. In all cases, as 
controls also non UV irradiated samples were analyzed in parallel (lanes 6, 8 and 10). 
The crosslinking sites of Cwc2 on U6 snRNA were mapped at different stages of spliceosome 
assembly, namely the Bact, the B* and the C complex (Figure 3.5, Figure 3.6 and Figure 3.7) 
while crosslinks of Cwc2 on the pre-mRNA were only localized at the stage of the Bact 
complex (Figure 3.9). 
 
In all three complexes, a strong reverse transcriptase stop was observed at U6 snRNA 
nucleotide G39 (located just upstream of the U6 ACAGAGA box), four weaker stops at 
nucleotides U65–C68 (in the stem of the U6-ISL), and one at U74 (in the loop of the U6-
ISL)(see below for a summary). All of them were dependent on UV irradiation of 
spliceosomes (lanes 6–9 in Figure 3.5, Figure 3.6 and Figure 3.7) and were not observed after 
UV irradiation of in vitro transcribed U6 snRNA (lanes 10 and 11).  All of these 
spliceosome-dependent reverse transcriptase stops were observed exclusively when 
crosslinked TAP-Cwc2-RNA species were specifically precipitated with IgG Sepharose 
under denaturing conditions, indicating that the protein contacting these nucleotides in native 
 
Figure 3.8: RNase H cleavage and immunoprecipitation of Cwc2-TAP after UV crosslinking of the 
spliceosomal C complex 
Digestion of  U6 snRNA after DNA oligonucleotide-directed  RNase H cleavage of in vitro transcribed U6 
snRNA (lane 1) and U6 snRNA from purified C complexes after crosslinking and immunoprecipitation with 







Bact complexes was indeed Cwc2 (lanes 6 and 7, Figure 3.5). While the Cwc2 crosslink to 
G39 appeared to be equally strong in all three complexes, there were differences in the 
intensity of the weaker stops. In the C complex, significant stops were observed at 
nucleotides U65, C68, and U74 but not at nucleotides C66 and C67, while in complex B* the 
stops at nucleotides U65, C68, and U74 were less intense than in complex C. These minor 
differences observed in crosslinks in the loop and stem of the U6-ISL, suggest changes in the 
interaction between Cwc2 and the ISL during the catalytic phase of the spliceosome cycle, 
which could in turn suggest the possibility of conformational changes in the ISL at this stage 
of splicing.  The signals from nucleotides C85 to A90 were seen in the RNP samples (lanes 7 
and 9) and also in UV irradiated in vitro transcribed U6 snRNA (lane 11), indicating that 
these were reverse transcriptase stops due to RNA–RNA crosslinks between adjacent 
nucleotides or, alternatively, UV induced RNA damage. 
To obtain additional, independent experimental evidence that the crosslinks detected to the 
U6-ISL in the C complex were due to Cwc2 and not to a different protein, the purified 
crosslinked TAP–Cwc2–U6 RNA species was specifically cut into two pieces by oligo-
directed RNase H cleavage (Figure 3.8). RNase H is a non specific endonuclease, catalyzing 
the cleavage of RNA within an RNA- DNA duplex. For this purpose a DNA oligonucleotide 
was used that hybridized to nucleotides 42–61 of U6 snRNA. The sample was incubated with 
IgG Sepharose, allowing the selective immunoprecipitation of the 5’ and/or the 3’ portion of 
U6 snRNA (e.g., containing the U6-ISL) crosslinked to Cwc2-TAP. Co-precipitated RNAs 
were identified by Northern blotting using a probe that hybridizes to U6 snRNA. This 
experiment showed that both portions of U6 snRNA were precipitated, thereby demonstrating 
that the crosslinking sites detected in the U6-ISL at the stage of C complex were due to Cwc2 
(Figure 3.8).  
The localization of Cwc2 crosslinks on the pre-mRNA was carried out in an identical manner 
as described for U6 snRNA above. Primer extension analysis revealed a crosslink of Cwc2 to 
U222 of the M3Act∆6 pre-mRNA which corresponds to uridine +15 of the intron (Figure 3.9 
lane 7). U +15 was assigned as crosslink to Cwc2 among the other stops appearing in the IP 
manly for the following reasons. First, compared to the other signals, U +15 is strongly 
enriched after the precipitation (compare the intensities of signals between lanes 7 and 9). 
While in the input lane the intensity of the signal at U +16 is equal to U +15 and the 
intensities at nucleotides U +29 and U +30 are much higher, within the IP lane the intensities 





at this position within the RNA control (lane 11) is very weak compared to the RNP samples, 
an indication of a stop caused by crosslinked protein. Third, no signals are observed after the 
stop at U +15. If the pre-mRNA is precipitated via a crosslink of U +15 to Cwc2, all bound 
pre-mRNA will contain this crosslink since the non-crosslinked RNA is washed away. 
Therefore, the reverse transcriptase can never read through this nucleotide, while this is 
possible within the input (lane 9). Generally, during primer extension analysis of UV 
irradiated pre-mRNA a high background was observed, which was due to those additional 
signals.   
The crosslinking results are summarized in Figure 3.10 for Bact and C complexes, in the 
context of the U6/U2/pre-mRNA interaction network proposed for the catalytic center. The 
existence of crosslinks between Cwc2 and U6 G39, on the one hand, and between Cwc2 and 





Figure 3.9: Cwc2 interacts with the pre-mRNA intron 15 nucleotides downstream of the 5’SS.  
Primer-extension analysis of M3Act∆6 pre-mRNA derived from UV irradiated Bact complex, after 
immunoprecipitation with IgG sepharose (IP, lane 7) or without immunoprecipitation (input, lane 9). Analysis of 
UV irradiated M3Act∆6 RNA prepared by transcription in vitro (lane 11). The primer used was complementary 
to positions 254–269 of yeast M3Act∆6 pre-mRNA. The reverse-transcriptase stop that is due to an RNA– Cwc2 






simultaneously contact Cwc2, and thus are in close proximity in the spliceosome. As Cwc2 
also contacts the U6 ISL, one possible function of Cwc2 might be to orient and/or juxtapose 
the ISL region of U6 snRNA and the ACAGAGA/5’ SS RNA element (see Discussion). 
 
 
3.1  Structure probing of native and Cwc2-depleted Bact complexes 
 
The UV crosslinking experiments described above provide important information about the 
interaction sites of Cwc2 on U6 snRNA and the pre-mRNA. To get a better understanding of 
the whole interaction surface of Cwc2 within the spliceosomal RNA network, additionally, 
structure probing experiments were performed in cooperation with Dr. Olexandr Dybkov 
(Department of Cellular Biochemistry, MPI-BPC). During the course of these experiments, 
the reactivity of U6 snRNA within native spliceosomal complexes towards dimethylsulfate 
(DMS) and 1-cyclohexyl-3- (2- morpholinoethyl) carbodiimide metho-p-toluene sulfonate  
(CMCT) was assessed. For this purpose, purified Bact complexes either containing Cwc2, 
depleted of Cwc2 or depleted and supplemented with recombinant Cwc2, where treated with 





Figure 3.10: Crosslinks of Cwc2 in yeast Bact and C complexes 
Secondary-structure models of U2/U6/pre-mRNA before (Bact complex) and after (C complex) step 1 of splicing 
according to Madhani and Guthrie (1992). The attack of the branchpoint adenosine at the 5’ SS is indicated by an 
arrow in the Bact complex. Sites in U6 snRNA crosslinked to Cwc2 are indicated by red circles, open circles 
indicate weak, and closed circles indicate strong crosslinks, respectively. Green circle: site in the pre-mRNA 








Figure 3.11 Structure probing in native and ∆Cwc2 Bact complexes.  
 
Structure probing with DMS and CMCT. Lanes 5 and 6 (wt) ‘wild-type’ Bact complex, lanes 7 and 8 (∆) Bact 
complex assembled in ∆Cwc2 extract, and lanes 9 and 10 (∆+) Bact complex assembled in ∆Cwc2 extract 
supplemented with 1 µM recombinant Cwc2. In lanes 5, 7, and 9 (‘+’), the reaction mixture was complete, while 
in lanes 6, 8, and 10 (‘-’), the chemical reagent was omitted. G, C, U, A are sequencing ladders. The arrow 
indicates the U6 snRNA G39 nucleotide crosslinked to Cwc2. The positions of protected nucleotides in native 
purified complexes are shown on the right with blue stripes for DMS and red stripes for CMCT. Pink stripes 






extension. At a neutral pH, DMS primarily reacts with for Watson-Crick base pairing 
relevant positions of adenosine and cytidine, while CMCT on the other hand, at pH 8.0, 
primarily modifies uridine and guanine (Ehresmann et al, 1987). Under the buffer conditions 
used here, however, CMCT also modified to some extent adenosine and cytidine.  
In native Bact complexes, only a few nucleotides of the U6 snRNA were highly accessible 
towards modifications by DMS and CMCT (Figure 3.11 lanes 5). In case of DMS, these 
nucleotides were located primarily in the loop of the 5’ stem-loop (i.e., A12 and C14) and the 




Figure 3.12: Summary of the results obtained from structure probing in native and ∆Cwc2 Bact 
complexes 
 
Secondary-structure model of U2/U6/pre-mRNA before step 1 of splicing. The attack of the branch point 
adenosine at the 5’ SS is indicated by an arrow. Bases in U6 snRNA protected from modifications towards 
DMS and CMCT, respectively, in the presence of Cwc2, are represented by blue, red, and pink stripes 
superimposed on the secondary-structure models of the U6 snRNA. U6 snRNA crosslinks to Cwc2 are 
indicated by red circles, open circles indicate weak, and closed circles indicate strong crosslinks, 






U6-ISL. The strongest signals observed for CMCT were at U11, which is located in the loop 
of the 5’ stem-loop as well, and signals in the region between nucleotides C16 and A26. 
Importantly, the nucleotides flanking G39 and the loop of the U6-ISL, where the Cwc2 
crosslinks were mapped, are poorly or not at all accessible (lane 5 in both panels). In contrast, 
both regions became heavily accessible to DMS as well as to CMCT when Cwc2 was not 
present in the complex (lanes 5 and 7 in both panels), indicating that Cwc2 does not only 
interact with the nucleotides found to be crosslinked, but also with the nucleotides 
surrounding them. Additional nucleotides of U6 snRNA that became more accessible in 
∆Cwc2 Bact complexes compared to native Bact complexes include U80, the bulged out 
nucleotide within the U6-ISL coordinating a catalytically important Mg2+ ion, and several 
nucleotides within or flanking the ACAGAGA box such as U46, A51, U54 and nucleotides 
U88–U91 downstream of the U6-ISL (see Figure 3.12 for a summary of the U6 snRNA 
sequences that are protected in the presence of Cwc2). Importantly, the modification pattern 
of U6 snRNA in Bact complexes purified from Cwc2-depleted splicing extract which was 
supplemented with recombinant Cwc2 prior to spliceosome assembly, resembles closely the 
one observed with native purified Bact complexes (compare lane 9 with lanes 5 and 7 in both 
panels). This is particularly true for the regions around G39, the ACAGAGA box and the ISL 
loop and therefore indicates that the observed gain of accessibility in certain regions of U6 
snRNA upon depletion of Cwc2 is really due to the lack of Cwc2.  
Taken together with the crosslinking experiments these results clearly imply that within the 
Bact complex Cwc2 contacts the region upstream of the ACAGAGA box motif around G39 
and the U6-ISL. The increased accessibility of the region around the ACAGAGA box 
towards DMS and CMCT in the absence of Cwc2 indicates that these might also be 
interaction sites of Cwc2 with U6 snRNA. On the other hand, it might well be that in the 
absence of Cwc2 this whole area is somehow destabilized since Cwc2 seems to be a major 
scaffolding factor reinforcing the catalytic center of the spliceosome. 
 
 
3.2 Cwc2 is essential for step 1 of splicing in vitro  
 
To gain a better understanding of the role of Cwc2 in pre-mRNA splicing, in vitro splicing 
was performed with standard yeast splicing extracts depleted of Cwc2 (∆Cwc2 extracts). For 





Affinity Purification tag (TAP-tag) at its C-terminus (Puig et al, 2001). Yeast extracts were 
incubated either with IgG Sepharose, or (for mock depletion) with Protein A Sepharose.  
 
Subsequently, Western blot analysis using the PAP complex (peroxidase anti-peroxidase 
complex), which recognizes the TAP-tag, demonstrated that Cwc2 was efficiently depleted 
from the extract, while it was still present in the mock treated extract (Figure 3.13A, compare 
lanes 2 and 3). Yeast extracts depleted of Cwc2 were then assayed for their ability to splice 
Actin WT pre-mRNA. As shown in Figure 3.13, the mock depleted extract (lanes 4-6) spliced 
with an efficiency comparable to that of the control (1-3), while no splicing products or 
intermediates were observed in the reactions where the ∆Cwc2 extract was used. Since the 
depletion was performed under mild salt conditions (200 mM KCl, 2.2.3.3), it was important 
to prove that the observed effect on splicing was really due to the lack of Cwc2 and not 
caused by the co-depletion of some other factors, tightly interacting with Cwc2. Therefore, 
∆Cwc2 extract was supplemented with recombinant Cwc2, expressed in E. coli and 
subsequently purified, to test for its ability to reconstitute the splicing activity of the depleted 
extract. Since the activity of ∆Cwc2 extract (lanes 10-12) could be restored to a level 
comparable to that of the control extracts (lanes 1-6) by adding only recombinant Cwc2, it is 
evident that Cwc2 is essential for in vitro splicing. The purity of the recombinant protein was 
checked by SDS-PAGE and subsequent Coomassie staining (Figure 3.14:).  
 
Figure 3.13 Cwc2 is essential for step 1 of splicing in vitro  
 
(A) Western blot analysis of yeast splicing extracts carrying Cwc2 tagged with the TAP tag before (lanes 1 and 
2) and after depletion of Cwc2 (lane 3). (B) A uniformly radiolabelled M3Act pre-mRNA was incubated in yeast 
whole-cell extract (lanes 1–3), either mock- (lanes 4–6) or Cwc2-depleted (lanes 7–12), under standard splicing 
conditions. Recombinant Cwc2 was added to a final concentration of 3 μM (lanes 10–12). The splicing mixtures 
were incubated at 23 °C and stopped at the time indicated. RNA was analyzed on an 8% polyacrylamide gel and 







Shown are analyzed aliquots taken from fractions collected after size exclusion 
chromatography. No significant impurities were detected and for the reconstitution assay only 
the peak fractions 16 and 17 were used. To assess the influence of the Cwc2 depletion on 
complex formation and to get further proof that no other spliceosomal factors were co-
depleted during the depletion, spliceosomal complexes lacking Cwc2 (∆Cwc2 Bact 
complexes) were purified and analyzed. 
∆Cwc2 Bact complexes were purified essentially as described above only that yeast cell 
extract depleted of Cwc2 (∆Cwc2 extract) was used for the in vitro assembly. In this way it 
was possible to obtain spliceosomal complexes stalled at the stage of the Bact complex, just 
prior to the first catalytic step, which showed a sedimentation behavior similar to native Bact 
complexes and also had the respective snRNAs stably integrated (see also 3.3). To analyze 
the impact of the Cwc2 depletion on the spliceosomal proteome, mass spectrometry analysis 
with ∆Cwc2 Bact and native Bact complexes was performed. Table 3.1 shows one 
representative result of such an analysis in form of a direct comparison between the peptide 
numbers found in native Bact (column labeled “Bact”) and ∆Cwc2 Bact (column labeled 
“∆Cwc2”) complexes, respectively. These data indicate that apart from the significantly  
 
 
Figure 3.14: Purification of recombinant Cwc2 
 
After overexpression, recombinant Cwc2 was purified from E. coli cell lysate by Ni-NTA affinity 
chromatography and subsequent size exclusion chromatography. Fractions eluted after size exclusion 
chromatography were loaded on a SDS-polyacrylamide gel and visualized by Coomassie-staining. Shown are 







reduced amounts of Cwc2, the protein composition of ∆Cwc2 Bact complexes is qualitatively 





Table 3.1: MS analysis of native Bact and ∆Cwc2 Bact complexes 
Proteins were separated by SDS-PAGE and stained with Coomassie. Each lane of the gel cut into 23 slices and 
proteins therein were digested with trypsin. The received peptides were extracted and then analyzed by LC-





3.3 Cwc2 is not required for the activation of the spliceosome or 
for its remodelling by Prp2 
 
It was previously shown that Cwc2 is recruited to the spliceosome during its activation step, 
i.e. during the transition from complex B to Bact, when U1 and U4 snRNAs are dissociated. 
Therefore, it was investigated whether Cwc2 is required for this transition. To monitor this 
transition, the fact was exploited that complex B has a Svedberg (S) value of 40, while 
complex Bact to which it is transformed, has an S value of 45 (see also Figure 3.15 and 
Fabrizio et al (2009)). For this experiment a yeast strain was used containing a temperature-
sensitive Prp2 helicase (prp2-1) and also expressing Cwc2 with a C-terminal TAP tag (strain 
YNR1). Splicing extracts of these cells were depleted of endogenous Cwc2 (2.2.3.3), and the 
mutated Prp2 was heat inactivated prior to the in vitro splicing reaction by 30 min incubation 
at 35°C. The heat inactivation was necessary to block spliceosome assembly at the Bact stage 
(i.e. Bact∆Prp2 complex). Splicing was then initiated by adding 32P-labelled Actin WT pre-
mRNA that carried three MS2 RNA aptamers at its 5’end (M3Act pre-mRNA) and the 
splicing reaction was further incubated for 50 min at 23°C. The resulting spliceosomal 
complexes were purified via glycerol gradient centrifugation and MS2–MBP-based affinity 
chromatography (Fabrizio et al (2009), Warkocki et al (2009)) and subsequently examined by 
analytical ultracentrifugation in a second glycerol gradient. Figure 3.15 shows that most of 
the purified complex ∆Cwc2 Bact∆Prp2 had an S value of about 45. A parallel experiment using 
Cwc2 mock-depleted splicing extracts, but otherwise identical to the first, gave a very similar 
result (Figure 3.15, Bact∆Prp2). These results imply that the transition from complex B (40S) to 
Bact (45S) took place in both cases, implying that Cwc2 is not required for this process. This 
inference is supported by an RNA analysis of the isolated spliceosomal complexes (Figure 
3.16A): while 40S B complexes contain, as expected, all of the snRNPs U1, U2, U4, U5 and 
U6 in similar molar quantities (lane 1), the 45S spliceosomal complexes assembled in ∆Cwc2 
splicing extracts show only small quantities of U1 and U4 snRNAs, while U2, U5 and U6 
snRNAs are represented in quantities similarly to those found in the B complex, confirming 
the identity of the 45S particles as Bact (lane 2 compare with lane 3).  
These results further show that Cwc2, apart from being not needed for the activation of the 
spliceosome, is also not needed for the stable integration of the U5 and U6 snRNAs into the 
spliceosome during the B to Bact transition. Thus, Cwc2 clearly has a function distinct from 






of the activated spliceosome in an ATP-dependent step as a prerequisite for catalytic 
activation of the spliceosome (i.e., transition from the Bact to B* complex). This remodelling 
step results in a decrease in the S value of the spliceosome from 45S (Bact) to 40S (B*), a 
process which also involves the destabilization of the interaction of the U2 SF3a and SF3b 
proteins (Kim and Lin (1996); Warkocki et al (2009)). To investigate whether Cwc2 is 
involved in this Prp2- mediated remodeling step, we incubated affinity-purified 45S ∆Cwc2  
Bact∆Prp2 spliceosomes with Prp2, Spp2, and ATP for 30 min at 23°C and then analyzed their  
sedimentation behavior in a glycerol gradient. Figure 3.15 shows that the majority of these 
spliceosomes now sediment with an S value of ~40S (+Prp2, +Spp2, ∆Cwc2). Thus, efficient 
ATP-dependent Prp2 remodeling of the spliceosome can also occur in the absence of Cwc2. 
While the Prp2-remodelled ∆Cwc2 Bact complex (+Prp2, +Spp2, ∆Cwc2) exhibits a similar S 
value as a wild-type B* complex, it is catalytically inactive. This was shown by the following 
experiment (Figure 3.16A). Affinity-purified 45S ∆Cwc2 Bact∆Prp2 spliceosomes were 
incubated with Prp2, Spp2, ATP, and Cwc25 for 45 min at 23°C (lane 7). As a control, the  
 
 
Figure 3.15: Cwc2 is not required for the Prp2-mediated remodelling step 
Profiles of affinity-purified Bact spliceosomes depleted of Cwc2 (Bact ∆Cwc2), Bact ΔPrp2 ∆Cwc2 spliceosomes 
after incubation with Prp2/Spp2/ATP (+Prp2, Spp2 ∆Cwc2) and after incubation with Prp2/Spp2/ATP plus 
recombinant Cwc2 (+Prp2, Spp2 +Cwc2). Profiles of purified B complexes and Bact ΔPrp2 spliceosomes mock-
depleted of Cwc2 are also shown. Spliceosomes were separated on a glycerol gradient containing 75 mM 
KCl. The radioactivity contained in each gradient fraction was determined by Cherenkov counting. 
Sedimentation coefficients were determined by comparison with the UV absorbance profile of a reference 





same experiment was carried out except that purified 45S Bact∆Prp2 spliceosomes were Cwc2 
mock-depleted (lane 4). Only the Cwc2 containing spliceosomes were capable of carrying out 
catalytic step 1 of splicing (lane 4), while ∆Cwc2 Bact spliceosomes were catalytically 
inactive (lane 7), despite the fact that they can undergo the Prp2 mediated remodeling step. 
 
 
3.4 Cwc2 contains three potential RNA binding sites  
 
To gain a better understanding of how Cwc2 might be capable of interacting with several 
distinct RNA elements within the spliceosome and possibly even bring and hold them in 
close proximity to each other, mutational studies on Cwc2 have been performed in 





(A) RNAs isolated from the B and the ∆Cwc2 Bact complex (lanes 1 and 2) were visualized by northern blot 
analysis. Lane 3, RNAs isolated from complex Bact∆Prp2 (visualized by silver staining). RNA identities are 
indicated on the right. (B) Affinity-purified Bact∆Prp2 spliceosomes mock-depleted of Cwc2 (lane 4) and ∆Cwc2 
Bact∆Prp2 spliceosomes were incubated with Prp2, Spp2, ATP, and Cwc25 for 45 min at 23°C (lane 7).  






Recent high resolution crystal structures and sequence homology analysis have shown that 
Cwc2 consists of a conserved CCCH-type ZnF (zinc finger) and a conserved RRM (RNA 
recognition motif), both domains linked by a connector loop (Lu et al (2012); Schmitzova et 
al (2012), see also Figure 3.17). Cwc2 also contains an intrinsically disordered region at its 
C-terminus which has been described before as the interaction surface of Cwc2 with Prp19 
(Ohi and Gould (2002), Vander Kooi et al (2010)). While the RRM and the ZnF were 
obvious candidates for possible RNA recognition sites on Cwc2 also the connector loop was 
 
Figure 3.17: Domain structure and sequence alignment of Cwc2 (adapted from Schmitzova et al (2012)).  
(A) Schematic representation of domains and structural motifs in Cwc2. (B) Multiple sequence alignment of 
Cwc2 orthologs. S.c – Saccharomyces cerevisiae; K.l – Kluyveromyces lactis; Y.l – Yarrowia lipolytica; S.p – 
Schizosaccharomyces pombe; C.a – Candida albicans; C.n – Cryptococcus neoformans; H.s. – Homo sapiens. 
Darker background corresponds to higher sequence conservation. Icons above indicate secondary structure 
elements from the Cwc2 crystal structure. Magenta background corresponds to the RNA-crosslink sites. The 





considered to be involved in RNA interactions because it consists of a stretch of at least eight 
positively charged amino acids exposed to the solvent (Lu et al (2012),Schmitzova et al 
(2012)). To investigate the functional significance of these selected structural elements, point 
and truncation mutants of Cwc2 were expressed in E.coli and purified to homogeneity and 



































Figure 3.18: Effects of Cwc2 mutagenesis on its splicing activity.  
 
(A) Western blot analysis of yeast splicing extracts carrying TAP-tagged Cwc2 before depletion (lane 1) and 
after depletion of Cwc2 (lane 2). (B) Uniformly radiolabelled M3-ActWT pre-mRNA (0.4 nM) was incubated 
in 20% yeast whole-cell extract, which was either mock- (lanes 1,2) or Cwc2-depleted (lanes 3–10), under 
standard splicing conditions. Recombinant WT Cwc2 and mutant proteins indicated above each lane, were then 
added to a final concentration of 2 μM (lanes 4–10). The splicing reactions were incubated at 23°C for the 
indicated time points. RNA was analyzed on an 8% urea–polyacrylamide gel and visualized by 
autoradiography. The positions of the pre-mRNA, the splicing intermediates and products are indicated on the 
left. The intensities of the mRNA product signals were quantified using Quantity One. The signal of the Cwc2-
TAP extract (lane 2) was used as 100%, and relative to it the amount of mRNA produced was calculated. 
ΔCwc2 extract shows a residual level of mRNA of 16% (lane3) compared to 109% for ΔCwc2 extract 
supplemented with WT Cwc2 (lane 4), 97% with Cwc2ΔC (lane 5), 16% with RRM (lane 6), 50% with Y89A 






First, it was determined whether individual domains of Cwc2 alone were able to complement 
yeast extract depleted of Cwc2. Unfortunately, it was not possible to obtain a soluble 
fragment of Cwc2 spanning only the ZnF-Torus module. The RRM domain (residues 124-
234) on the other hand could be expressed and purified, but it did not have any impact on the 
splicing activity (Figure 3.18, lane 6). The Cwc2 structure, and crosslinking experiments of 
binary U6 snRNA-Cwc2 complexes formed in vitro, show that the two RNP motifs of the 
RRM are exposed to the solvent and able to bind RNA (Schmitzova et al, 2012).  
According to McGrail et al (2009), however, single-point mutations in amino acids Y138 and 
F183 (both of which are located in the RNP2 and RNP1 motifs of Cwc2, respectively) are not 
lethal. These results imply that the binding of RNA to the Cwc2-RRM is complex in nature 
and may involve cooperation with neighbouring regions of Cwc2. For this reason, the focus 
of the following mutational studies is directed more towards the ZnF and especially to the 
connector loop. The ZnF belongs to the TIS11d protein domain family (Lu et al, 2012). In 
this type of ZnF two conserved aromatic residues are usually required for stacking 
interactions with RNA. However, only one of these amino acids is conserved and exposed to 
the solvent in Cwc2, namely Y89 (Lu et al (2012), Schmitzova et al (2012)). When standard 
yeast splicing extract depleted of Cwc2 (∆Cwc2 extract) was supplemented with the point 
mutant Cwc2-Y89A, the splicing activity of the depleted extract could be restored only to a 
low level (35% activity, compared with the wild type Cwc2 protein; Figure 3.18, lane 7), 
supporting the concept of a significant role of residue Y89 and, accordingly, of the entire ZnF 
for the function of Cwc2. To assess the importance of the connector element, also point 
mutations of Y120, K132 and F130 to alanine were analyzed for their ability to complement 
∆Cwc2 extract. The substitution of Y120 completely abolished the ability of Cwc2 to restore 
the splicing activity of the depleted extract (Figure 3.18, lane 8), while the mutations at K132 
and F130 led to a significant decrease of activity (mRNA formation levels of ca. 60% and 
50%, respectively, compared to complementation with the wild type protein (Figure 3.18, 
lanes 9–10). These results illustrate a major role of the connector element during in vitro 
splicing. Taken together with the crosslinking results obtained from the binary U6 snRNA-
Cwc2 complexes in which Y120/R121 were found to crosslink to U6 snRNA (Schmitzova et 
al, 2012) this loop might have a pivotal role in RNA binding. 
A Cwc2 truncation (Cwc2∆C, residues 1-234) lacking the C-terminal part, the region of 
Cwc2 required for interactions with Prp19, was also assessed for its ability to restore the 





complemented with WT Cwc2 or Cwc2∆C, respectively, could be observed (Figure 3.18, 
compare lanes 4 and 5), indicating that Cwc2∆C represents the functional core of Cwc2 and 
the interaction of Cwc2 with Prp19 is not essential for in vitro splicing.   
 
 
3.5 RBM22, the human homologue of Cwc2, interacts with U6 
snRNA at sites equivalent to those contacted by Cwc2 in yeast 
spliceosomes 
 
As Cwc2 is essential for step 1 of splicing in yeast, it is highly likely that its interaction with 
U6 snRNA (and potentially also with the pre-mRNA) is a prerequisite for step 1. If such a 
centrally positioned RNA–protein interaction is indeed of functional importance, it should be 
highly conserved through evolution. To address this question, the observed interactions of 
Cwc2 with the spliceosomal RNA network were compared to those of RBM22 within the 
human spliceosome. RBM22 is the human homologue of Cwc2 (McGrail et al, 2009)(see 
also Figure 3.19). Although sequence comparisons between both proteins show only an 
overall similarity of 27%, the central region comprising the ZnF and the RRM is conserved as 
shown also above (39% similarity, 26% identity, see Figure 3.19). RBM22 has also been 
classified as NTC-related protein being an integral component of human spliceosomal 
complexes B and C (Bessonov et al, 2008; Deckert et al, 2006). In previous work (Bessonov 
et al, 2008; Deckert et al, 2006), the yeast protein Ecm2 was considered as the homologue of 
RBM22 and a closer look at the sequence revealed that this conservation is mainly restricted 
to the N-terminal part of RBM22 spanning amino acids 21-145 (51% similarity and 37% 
identity, Figure 3.19). Therefore, different regions of RBM22 show homology to two 
different proteins from S. cerevisiae. Like for Cwc2, it was also shown that RBM22 is 
required for pre-mRNA splicing in vitro and that it can be crosslinked to U6 snRNA and pre-
mRNA in purified human Bact and C complexes (Rasche et al, 2012). Interestingly, the 
crosslinks of RBM22 to U6 snRNA within the Bact complex were mapped to nucleotides 
upstream of the ACAGAGA box motif and to a lesser extend also to the U6-ISL (Figure 
3.20). The contact sites of RBM22 therefore are located approximately in the same regions of 







crosslinks to the U6-ISL accumulated. Also in case of Cwc2 an increased crosslinking yield 
was observed after step one of splicing.  
The crosslinks of RBM22 to the pre-mRNA were mapped to intron nucleotides +26 to +28 
upstream of the 5’SS, again corresponding to a similar region where the Cwc2 crosslinks 
were found. In summary, RBM22 interacts with both the U6 snRNA and the pre-mRNA in 
the human spliceosome similarly to its yeast counterpart Cwc2, and its interaction sites on the 
U6 snRNA are conserved in both organisms. The evolutionarily highly conserved nature of 




Figure 3.19: The N-terminal portion of RBM22, the human homolog of Cwc2, shares 
homology with S. cerevisiae Ecm2. 
 
A database search with the human protein RBM22 sequence retrieved both Ecm2 and Cwc2 from S. 
cerevisiae and revealed that the N-terminal part of RBM22 (amino acids (aa) 21-145) is highly 
evolutionarily conserved (51% similarity, 37% identity) to that of Ecm2 (aa 10-128). The central and C-
terminal part of RBM22 (aa 164-303), which includes Zn-fingers and RRM, is in turn homologous to Cwc2 
(aa 72-226) (39% similarity, 26% identity). Identical amino acids are shown in yellow and similar amino 











Figure 3.20: Comparison of Cwc2 and RBM22 crosslinks within yeast and human spliceosomes 
Secondary-structure models of yeast (upper panel) and human (lower panel) U2/U6/pre-mRNA network before 
(Bact complex) and after (C complex) step 1 of splicing. The attack of the branchpoint adenosine at the 5’ SS is 
indicated by an arrow in the Bact complex. Sites in U6 snRNA crosslinked to Cwc2/RBM22 are indicated by red 
circles, open circles indicate weak, and closed circles indicate strong crosslinks, respectively. Green circle: sites 







The recently published crystal structure of a self-splicing group IIC intron (Toor et al, 2008a) 
revealed that the central element of the group II catalytic center, stem-loop DV, is enclosed 
by a large RNA network consisting mainly of DI of the intron, which leads to the 
arrangement of DV in a specific, catalytically active conformation by several long-range 
interactions. Group II introns and the spliceosome are believed to have a common ancestor 
which is reflected in particular by the high similarity observed between DV of group II 
introns and the U6-ISL. Under the premise that both processes are related and the mechanism 
of catalysis is similar, the interactions described for DV and DI in group II introns may be 
accomplished by snRNAs or by protein factors within the spliceosome. This circumstance is 
of particular interest since it was shown, that during the transition from B to Bact complex 
almost all known U6 snRNA interaction partners are leaving the spliceosome (Fabrizio et al, 
2009). To discover a possible interaction partner of U6 snRNA and to characterize its role 
during splicing a crosslinking approach was applied.  
 
 
4.1 Cwc2 interacts with catalytic RNA-structural elements in the 
spliceosome 
 
Several spliceosomal factors were previously implicated in interactions with U6 snRNA. 
Prp8 for example, one of the largest and most highly conserved nuclear proteins, occupies a 
central position in the catalytic core of the spliceosome (Grainger & Beggs, 2005), and it has 
been shown to crosslink not only to U6 snRNA (Vidal et al, 1999), but also to U5 snRNA 
within the tri-snRNP (Dix et al, 1998) and to multiple regions of the pre-mRNA within 
spliceosomes (Vijayraghavan et al (1986), Whittaker and Beggs (1991), Turner et al (2006)). 
Likewise, also the NTC related protein Ecm2 has been shown to be involved in the formation 
of U2/U6 helix II during the activation of the spliceosome (Xu & Friesen, 2001). Both factors 
were obvious candidates for initial crosslinking trials in activated spliceosomes. However, 
under the experimental conditions used during this work none of these factors could be 





mRNA while Ecm2 could only be crosslinked to the pre-mRNA. Besides these two proteins, 
additional potential U6 snRNA interactions with Yju2, Cwc2 and the U5 component Snu114 
were investigated. Snu114 could be crosslinked to U5 snRNA, to U2 snRNA and the pre-
mRNA while Ecm2 showed crosslinks to the pre-mRNA and Cwc2 to the pre-mRNA and U6 
snRNA, demonstrating a very selective crosslinking behavior of the five proteins tested. 
Cwc2, the only protein found here to be crosslinked to U6 snRNA, is a member of the group 
of NTC-related proteins that, along with the core NTC complex, are stably integrated into the 
Bact complex during the activation of the spliceosome. The results obtained during this work 
show that Cwc2 is essential for the formation of a catalytically competent spliceosome, but it 
does not act until the late spliceosome maturation phase, just prior or during step 1 of 
splicing.  
An indication for a possible function of Cwc2 is provided by the data obtained through 
additional protein-RNA UV crosslinking studies conducted with purified yeast spliceosomes 
in the activation/catalytic phase (Bact, B*, and C). In all of these complexes, Cwc2 contacts 
two regions of U6 snRNA, namely nucleotides around G39, upstream of the ACAGAGA 
box, which is base paired with the 5’ SS, and the left part of the U6-ISL including the ISL 
loop (Figure 3.5, Figure 3.6, Figure 3.7). It is instructive to examine the Cwc2-U6 snRNA 
interactions in more detail and to compare them between the various spliceosomal complexes 
analyzed. Crosslinking of Cwc2 to U6-G39 takes place already in complex Bact, with an 
efficiency equal to that observed with B* and C complexes (Figure 3.5, Figure 3.6, Figure 
3.7). In contrast, the interaction of Cwc2 with the U6-ISL is more dynamic, in that the 
crosslinking pattern changes during the transition from Bact to B* to C (Figure 3.5, Figure 3.6, 
Figure 3.7). In the Bact complex, only a low degree of crosslinking to U74 in the terminal loop 
and to U65–C68 on the 5’ side of the stem is observed (Figure 3.5). While the intensity of the 
Cwc2 crosslink to U6-G39 is similar in all three complexes, the crosslinking of Cwc2 to the 
ISL is more pronounced in B* and especially in the C complex, in which the greatest degree 
of Cwc2 crosslinking is observed for U65 and C68 with little or no crosslinks formed with 
C66 and C67. To gain additional proof for Cwc2 interacting with G39 of U6 snRNA and the 
ISL at the same time, a DNA-oligo-directed RNase H digestion was performed, 
demonstrating that Cwc2 indeed crosslinks to both parts of U6 snRNA (Figure 3.8). This 
observed change in crosslinking behavior suggests that the conformation of the U6-ISL is 
remodeled during the catalytic activation by Prp2/Spp2 and also during the transition to the 





To get a better understanding of the whole interaction surface of Cwc2 within the 
spliceosomal RNA network, additionally, structure probing experiments were performed. 
Upon depletion of Cwc2 from spliceosomal complexes indeed the regions around G39 and 
the U6-ISL loop, where the UV induced crosslinks are found, become more accessible 
towards chemical modifications (Figure 3.11). The enhanced accessibility of the U6 snRNA 
nucleotides C33-C43 in ∆Cwc2 Bact compared with native Bact complexes, suggests that 
Cwc2 probably contacts a longer stretch of the U6 snRNA, both upstream and downstream of 
G39.  
Besides the areas where the crosslinking sites are located also other nucleotides of U6 snRNA 
became more accessible in ∆Cwc2 Bact complexes compared to native Bact complexes, 
including U80, the bulged out nucleotide within the U6-ISL coordinating a catalytically 
important Mg2+ ion, and several nucleotides within or flanking the ACAGAGA box such as 
U46, A51, U54 and nucleotides U88–U91 downstream of the U6-ISL. However, in these 
cases it is not clear if this is a matter of direct Cwc2-U6 interactions or an indirect 
destabilization effect induced by the absence of Cwc2.   
Taken together, these data indicate that one function of Cwc2 in the spliceosome could be to 
bring, or to help to keep, two functionally important RNA-structural elements close to one 
another, namely the ACAGAGA box/5’ SS element and the U6-ISL.   
Interestingly, Cwc2 can also be crosslinked to a U at intron position +15 (relative to the 5’ 
SS, Figure 3.9), indicating that this region must be close to the G39-containing region of U6 
snRNA, upstream of the ACAGAGA box. By binding simultaneously to both of these single-
stranded regions (U6 snRNA and the intron), which are both close to the ACAGAGA/5’ SS 
element, Cwc2 could play a role in tethering this entire region to the U6-ISL. It is also 
possible that the simultaneous binding of Cwc2 to the U6-G39 and intron U+15 region 
reinforces or modulates the interaction between the ACAGAGA box and the 5’ SS. In this 
context, it is important to note that several nucleotides in and around the ACAGAGA box 
were found to be accessible to chemical reagents in the ∆Cwc2 Bact, but not in the native Bact 
complex. The same is true for some U6 snRNA nucleotides in the U6/U2 helix I, especially 
for U6-C61 (Figure 3.11). This is consistent with the idea that Cwc2 also interacts with the 
ACAGAGA box/5’ SS and helix I. However, in the absence of Cwc2 crosslinks in these 
regions, it cannot be excluded that one or more other proteins interact with these regions in a 
Cwc2-dependent manner. It is also possible that Cwc2 stabilizes a specific conformation of 





destabilized or distorted, thus making the function of Cwc2 fundamental. Recently, it was 
shown that the U6 ACAGAGA box is dynamically base paired with the 5’ SS, in a manner 
dependent upon the NTC complex (Chan & Cheng, 2005). As Cwc2 interacts with at least 
two proteins of the core NTC complex (i.e. Isy1 and Prp19) (Ohi & Gould, 2002), it is 
conceivable that the NTC together with Cwc2 modulates the interaction between the U6 
snRNA and the 5’ SS. In their RNA-RNA crosslinking study Chan and Cheng (2005) noted 
that U6-G39 was crosslinked to an unidentified protein; it seems very likely that this is the 
Cwc2 crosslink described in this work. 
 
 
4.2 Cwc2 is required for pre-mRNA splicing in vitro and it is not 
required for the Prp2-mediated remodeling of the activated 
spliceosome 
  
The crosslinking and structure probing experiments discussed above demonstrate that Cwc2 
interacts with several important RNA elements close to the spliceosomal catalytic core. 
Therefore depletion and reconstitution experiments should provide additional information 
about the functional relevance of Cwc2 during splicing.    
The depletion of Cwc2 from yeast splicing extracts leads to inhibition of splicing prior to step 
1 of splicing (Figure 3.13). In the absence of Cwc2, however, a stable complex that (like a 
native Bact complex) has an S value of 45, could be purified. This Bact-like complex no longer 
contains U1 or U4 snRNAs and possesses stably integrated U5 and U6 snRNAs (Figure 
3.16A) indicating that Cwc2 is not required for the formation of Bact complex. Additionally, 
mass spectrometry analysis of the isolated ∆Cwc2 Bact complexes revealed that their protein 
composition, apart from the absence of Cwc2, is qualitatively identical to that of the native 
Bact complexes demonstrating that Cwc2 is also not needed for the recruitment of the NTC 
(Table 3.1).  
Further experiments showed that Cwc2 is not required for the Prp2/Spp2- and ATP-
dependent remodeling of the Bact complex from a 45S to 40S spliceosomal complex (Figure 
3.15), a process that is accompanied by destabilization of the binding of the U2-SF3a and 
SF3b proteins (Warkocki et al, 2009). In addition, Cwc2 unlike other proteins, which 





the entire catalytic phase. Thus, due to its close association with the catalytic RNA network, 
it is likely that Cwc2 is required not only for step 1, but also for step 2 of splicing. 
 
 
4.3 Structural requirements of Cwc2 for multiple RNA 
interactions 
 
A reductionist crosslinking approach in a binary system composed of recombinant Cwc2 and 
in vitro transcribed U6 snRNA suggested several interaction sites of Cwc2 with U6 snRNA 
(Schmitzova et al, 2012), which would be consistent with the results obtained during this 
work. Here it was shown that Cwc2 directly interacts with at least three different important 
RNA elements within the spliceosomal RNA network, the U6 snRNA upstream of the 
ACAGAGA box motif, the U6-ISL and the pre-mRNA just upstream of the 5’SS. Therefore, 
the structure of Cwc2 was analyzed to localize regions possibly involved in these RNA 
interactions.  
Cwc2 adopts a compact, globular fold comprising nine α-helices (a1–a9), five 310 helices 
(η1–η5) and four β-strands (β1–β4; Figure 4.1) and the two predicted RNA-binding motifs 
of Cwc2, the ZnF and the RRM domains are readily recognized in the crystal structure. The 
RRM domain (residues 134–226), accounts for about 40% of the whole structure and exhibits 
a typical topology, with a four-stranded β-sheet (β1–β4) packed against two α-helices (α8, 
α9). The RRM domain contains two well-conserved sequence motifs commonly referred to 
as RNP1 and RNP2 which comprise two aromatic residues (Y138 of RNP2 and F183 of 
RNP1) that usually undergo stacking interactions with RNA bases. The crystal structure of 
Cwc2 demonstrates that all of the residues in general necessary for RNA binding by an RRM 
domain are exposed to the solvent, which is consistent with potential RNA-binding properties 
of this domain. 
The CCCH type ZnF domain folds into a common circular conformation in which three 
cysteine residues (C73, C81, C87) and one histidine residue (H91) coordinate the zinc ion. 
The ZnF exhibits a fold that is similar to those observed in the crystal structures of TIS11d 






An interesting feature of the Cwc2 fold is a massive toroidal structure enclosing the ZnF. 
This enclosure is formed by the regions flanking the ZnF (3–72 and 92–115) and since it has 
a certain analogy to a ring on a finger, it is referred to as Torus domain. This Torus domain is 
anchored to the ZnF mainly through several conserved hydrophobic residues and it represents 
the integrating element of the whole assembly, connecting tightly the ZnF and the RRM 
domain in one folding unit. 
At the sequence level, the C-terminal part of the Torus is connected to the N-terminal part of 
the RRM domain by a linker (residues 116–133), the connector element. Interestingly, this 
 
 
Figure 4.1: Overall crystal structure of Cwc2 (adapted from Schmitzova et al (2012)) 
Overall crystal structure of Cwc2 in a ribbon representation. Secondary structure elements and termini are 
labelled. Red, ZnF domain; blue, Torus domain; green, RRM domain; yellow, variable insertions; orange, 





connector element contains three conserved aromatic and three conserved positively charged 
residues, suggesting a possible role of this element in RNA interactions. Using an in vitro 
complementation splicing assay, it could be shown that a point mutation in the ZnF (Y89A) 
inhibits Cwc2 splicing activity significantly (ca. 65%), while a point mutation in the 
connector element (Y120A) abolishes activity almost completely (Figure 3.18B). Although 
based only on this assay it is not possible to directly link the reduction in splicing activity to a 
defect of Cwc2 in RNA-binding, it nevertheless seems to be the most plausible interpretation 
since aromatic residues of other ZnF domains corresponding to Y89 in Cwc2 are known to be 
crucial for RNA-binding (Hudson et al, 2004; Teplova & Patel, 2008). The region around 
Y120 (residues Y120-R121) can even be directly crosslinked to U6 snRNA within the binary 
U6-Cwc2 complex and its mutation also affects RNA binding according to performed EMSA 
experiments (Schmitzova et al, 2012), indicating that a loss of splicing activity indeed reflects 
a defect of Cwc2 in RNA binding.  
Besides the functional data provided by the mutational studies, a total of six crosslinking 
sites, which were located in the ZnF (C87), in the connector element (Y120-R121), in the 
RRM (K152, C181 from RNP1 and Y138 from RNP2) and in the Torus domain (F47), 
adjacent to the RNA binding side of the RRM domain could be identified by Schmitzova et al 
(2012) also providing strong support for the hypothesis that Cwc2 is indeed a multipartite 
RNA-binding protein, which exhibits the biophysical composition allowing it to organise 
several RNA elements. 
 
 
4.4 Evolutionary conservation of Cwc2 function in splicing 
 
That the interaction between Cwc2 and spliceosomal catalytic RNA elements described here 
is of functional importance is strongly supported by its striking evolutionary conservation. 
Like its yeast counterpart the human homologue of Cwc2, RBM22 (McGrail et al, 2009) is 
required for step 1 of splicing in vitro (Rasche et al, 2012). In isolated human Bact and C 
complexes, RBM22 also is crosslinked to the corresponding regions of the human U6 snRNA 
i.e., the region upstream of the ACAGAGA box (G34 and A24–U26) and to nucleotides in 
the terminal loop of U6-ISL and to C62 in its stem (see Figure 3.20). Furthermore, the 
differential yield of crosslinks between RBM22 and the U6-ISL in the Bact versus C complex 





contacts intron nucleotides near the ACAGAGA/5’ SS box interaction site, although the 
crosslinks are located somewhat further downstream than in the yeast spliceosome. Thus, also 
in higher eukaryotes, this protein appears to aid in tethering of the ACAGAGA/5’ SS 
interaction elements to the U6-ISL. Close proximity between the ACAGAGA/5' SS element 
and the U6-ISL, as indicated by the crosslinks between both of these regions and 
Cwc2/RBM22, is supported by previous site-directed hydroxyl-radical footprinting 
experiments with the Fe-BABE (iron(S)-1-(p-bromoacetamidobenzyl) 
ethylenediaminetetraacetate) reagent placed at position +10 of the introns in human Bact/B* 
and C complexes. In both complexes, cleavages were detected not only 5’ of the ACAGAGA 
box, but also in the upper region of the U6-ISL (Rhode et al (2006), see also Figure 4.2). 
 
Contact between RNA and Cwc2/RBM22 in the spliceosome is consistent with the presence 
of at least two potential RNA binding domains in both proteins - an RRM and a zinc finger - 










Figure 4.2: Hydroxyl-radical cleavages and RBM22 U6-ISL crosslinks projected onto the crystal structure 
of DV  
Snapshots of DV taken from the crystal structure of the group IIC intron from O. iheyensis (Toor et al, 2008a). 
The left panel represents a top view, the right panel a side view of DV. Catalytic Mg2+ ions are shown as grey 
spheres. Crosslinks of RBM22 to the U6-ISL are marked at analogous positions in DV (green nucleotides). 
Hydroxyl radical cleavages found in the U6-ISL with the Fe-BABE reagent placed at position +10 of the introns 
in human Bact/B* and C complexes (Rhode et al, 2006), are represented at analogous positions in DV (yellow 






finger-like sequence that, although absent in Cwc2, shows a clear sequence relationship with 
a zinc fingerlike sequence in yeast Ecm2 (Xu and Friesen (2001), Figure 3.17). No other 
human spliceosomal protein exhibits significant homology with yeast Ecm2. This raises the 
interesting possibility that RBM22 might represent a fusion protein of yeast Ecm2 and Cwc2, 
and thus functionally replace both proteins. Interestingly, Ecm2 was previously shown to play 




4.5 Cwc2: a link between the RNA-catalytic center and the protein 
network of the spliceosome 
 
The multiple interactions between Cwc2 and the catalytic RNA network of the spliceosome 
together with its interactions with proteins of the core NTC complex such as Prp19 and Isy1 
(Ohi and Gould, 2002) suggest that Cwc2 is an important link between the catalytic RNA 
network and factors that modulate the activity and the fidelity of the catalytic center (Hogg et 
al, 2010). On the basis of elegant genetic studies, a two-state model of the spliceosome has 
recently been proposed in which the conformations required for the first and second steps are 
in thermodynamic equilibrium (Konarska & Query, 2005a; Konarska et al, 2006). 
Interestingly, the two states can be stabilized/destabilized by various proteins and U6 snRNA 
mutant alleles that affect the efficiency and fidelity of step 1 or step 2, respectively (Konarska 
and Query, 2005). How these conformational changes are achieved at a molecular level is at 
present unclear. Due to the high degree of connectivity among spliceosomal proteins, local 
changes in the structure of the spliceosome -caused by certain protein or RNA mutations- 
could also be transmitted to the catalytic RNA network via Cwc2, thereby modulating the 
activity and/or fidelity of the catalytic center. Consistent with this possibility is the 
observation that the deletion of the NTC protein Isy1, which appears to interact with Cwc2 







4.6 A potential role for Cwc2/RBM22 in promoting an active 
conformation of the spliceosome’s catalytic RNA elements 
 
 
The recently published crystal structure of a self-splicing group IIC intron (Toor et al, 2008a) 
revealed how the central element of the group II catalytic center, stem-loop DV, is brought 
into a specific, catalytically active conformation by several long-range interactions. The 
upper and lower stems of DV are positioned at a 45° angle (relative to each other), which 
distorts the conformation of the bulge separating these stems and moves it into the vicinity of 
the catalytic RGC triad at the foot of the lower stem of DV (Keating et al, 2010; Toor et al, 
2010). At the same time, the nucleotides of the catalytic triad form a catalytic triple helix 
together with C377 of the DV bulge and the J2/3 GC dinucleotides (GA in group IIA and B 
introns), bringing together catalytically essential residues of the introns (Keating et al (2010), 
see also Figure 4.3 and Figure 4.4). In this constellation, the DV bulge and the triple helix 
together co-ordinate two Mg2+ ions in a configuration that is consistent with a two-metal-ion 
mechanism of splicing catalysis (Steitz & Steitz, 1993).  
An important feature of this is that formation of the catalytically active conformation of the 
DV stem-loop requires the entire group II intron structure. The U6-ISL together with the 
U6/U2 helix Ib -which contains the catalytic U6-AGC triad- possesses all the biophysical 
properties of the DV element of group II introns and is a central, catalytically essential RNA 
element of the spliceosome (see above). This idea is supported strongly by the demonstration 
that, in the minor spliceosome, a group II intron DV stem-loop can replace the U6atac-ISL 
without loss of splicing activity (Shukla & Padgett, 2002). It has further been suggested that 
the catalytically important J2/3 GA dinucleotide may have a spliceosomal counterpart in the 
3’-terminal GA of the U6 ACAGAGA box, which together with the U6-ISL bulge (U80 in 
yeast) could form a catalytic triplex with the AGC triad of the U6/U2 helix Ib (Keating et al, 
2010). However, this would require that (i) the upper part of the ISL stem adopts a similarly 
angular, distorted conformation with respect to the bottom part and (ii) both the ACAGAGA 
box and the 5’ SS are positioned in proximity to helix Ib and the ISL. As there are no 
obviously conserved RNA elements in the spliceosome that, analogous to the situation in 
group II introns, could induce a catalytically active conformation of the U6-ISL, this task 
must at least partly be performed by proteins. The results obtained during this work indicate 
that Cwc2 is an ideal candidate for performing such a task. By tethering the partially base 






indirectly with part of helix I and the ACAGAGA box (Figure 3.11), it could help to promote 
the formation of the putative catalytic triple helix discussed above. Moreover, by interacting 
with the terminal loop and the 5’ part of the stem of the U6-ISL, Cwc2 could potentially also 
promote an active conformation of the ISL. Thus, in the spliceosome, Cwc2 could, at least in 
part, substitute for the DI domain that in group II introns is responsible for inducing an active 
conformation of DV. However, whether the proposed catalytic triple helix (Keating et al, 
2010; Toor et al, 2008a) indeed forms in the spliceosome remains to be seen. Cwc2 could 
potentially even play a more active role in the creation of an active site by forming direct 
hydrogen bonds with nucleotides of the catalytic AGC triad in helix Ib and in this way 
replace one or more of the proposed base triplet interactions. The observed interactions of 
Cwc2 with the catalytic RNA structural elements of the spliceosome place Cwc2 at the heart 
of the catalytic center. Another protein situated close to the active site of the spliceosome is 
Prp8 (Grainger & Beggs, 2005). Prp8 contacts all of the chemically reactive sites of the  
 
Figure 4.3: Domain DV structure showing interactions with other domains (adapted from Keating et al 
(2010).  
 
(A) Secondary structure of domain DV. (B) Representation of the domain DV tertiary structure. The catalytic 
bulge of domain DV is shown in brown, while the rest of domain DV is shown in red. The upstream terminus of 
the intron is shown in green and J2/3 is blue. The group II intron structural analysis was conducted on the 
refined model with pdb code 3EOH (Toor et al, 2008b). All interactions described and shown here are also 






spliceosome, and it harbours an RNase H-like domain in its C-terminal region (Pena et al, 
2008; Ritchie et al, 2008; Yang et al, 2008), which helps to assemble and stabilize the 
spliceosome’s catalytic core. As Prp8 and Cwc2 contact distinct regions of the catalytically 
important RNA elements of the spliceosome, the two proteins appear to cooperate in 
promoting a catalytically active conformation of the spliceosomal RNA-RNA interaction 
network (see above and Butcher and Brow (2005)). The essential nature of the collaboration 
between spliceosomal RNA elements and both Cwc2 and Prp8 in catalyzing the splicing 
reaction, along with its evolutionary conservation, supports the idea that the spliceosome is 





The starting point of this thesis was the hypothesis that essential contacts between DV and DI 
in group II self-splicing introns also might exist within the spliceosomal context between the 
U6-ISL and some other yet unknown factors. Extensive RNA analysis revealed that the yeast 
 
Figure 4.4: Tertiary interactions involving DV and, hypothetically, U6 snRNA (adapted from Keating et 
al (2010) ) . 
  
(A) Interactions observed crystallographically for the Oceanobacillus iheyensis group IIC intron. (B) Cognate 
interactions inferred for the ai5γ group IIB intron. (C) Cognate interactions inferred for the eukaryotic 
spliceosome. The secondary structural representation derives from a U6 helix 1b model for the human 





protein Cwc2 is in close contact with regions of the U6-ISL. Remarkably, a comparison 
between these interactions and those observed between DV and DI of group II introns 
revealed several similarities. What still remains unclear is the attribution of the RNA 
crosslinks to a certain region of Cwc2 and how other factors interact with the spliceosomal 
RNA network. Although efforts were made to address these questions, definite answers are 
still missing. A promising approach towards a better understanding of these important points 
is the implementation of mass spectrometry to analyze protein-RNA crosslinks derived from 
purified and subsequently crosslinked spliceosomes. For a binary system, consisting of 
recombinant Cwc2 and in vitro transcribed U6 snRNA, this approach has already been 
proven useful (Schmitzova et al, 2012). Unfortunately, analyses of this kind are very material 
demanding and up to now it was not possible to purify sufficient amounts of spliceosomes 
from S. cerevisiae for such experiments. However, first attempts have been made to scale up 
the yeast spliceosome purification obtaining preliminary promising results. In this way, 
several additional questions could be addressed in the near future, allowing not only to 
characterize in more detail the interactions of Cwc2 with the spliceosome but also leading to 
discoveries of other important protein-RNA interactions. Structural analysis of spliceosomes 
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6.1 List of abbreviations 
 
3’SS   3‘ splice site 
5’SS    5‘ splice site 
°C    degree celsius 
A    adenosine 
ADP    adenosine-5‘-diphosphate 
APS    ammonium peroxy sulfate 
ATP    adenosine-5‘-triphosphate 
bp    basepair 
C    cytosine 
Ci    Curie 
CV   column volumes 
Da    Dalton 
DNA    deoxyribonucleic acid 
dNTPs   deoxynucleotide-5‘-triphosphates 
DTT    1,4- dithiothreitol 
EDTA   ethylendiamine-N, N, N‘, N‘-tetraacetic acid 
fmol    femtomole 
G    guanosine 
GDP    guanosine-5’-diphosphate 
GTP    gunosine-5’-triphosphate 
h    hour(s) 
kDa    kilo-Dalton 
l    liter 
Lsm    Like-Sm 
μ    micro 
μl    microliter 
μm    micrometer 





M    molar 
min    minute 
ml    milliliter 
mM    milimolar 
mRNA   messenger RNA 
MS    mass spectrometry 
n    nano 
nM    nanomolar 
nmol    nmol 
NP-40    Nonidet P-40 
nt    nucleotide 
NTPs    nucleotide-5’-triphosphates 
OD    optical density 
PAA    poly-acrylamide 
PAGE    poly-acrylamide gel electrophoresis 
PCI    phenol-chloroform-isoamylalcohol 
PCR    polymerase chain reaction 
PEG    polyethylene glycol 
pmol    picomole 
pre-mRNA   pre-messenger RNA 
Prp    pre-mRNA processing 
RNA    ribonucleic acid 
RNP    ribonucleoprotein 
RT    room temperature 
S    Svedberg 
S. cerevisiae   Saccharomyces cerevisiae 
SDS    sodium dodecylsulfate 
Sm    “Smith”, patient in which Sm proteins were first discovered 
snRNA   small nuclear ribonucleic acid 
snRNP   small nuclear ribonucleoprotein 
T    thymidine 
TBE    tris-borate-EDTA buffer 
TE    Tris-EDTA buffer 





U    uridine 
U snRNA   uridine rich small nuclear ribonucleic acid 
U snRNP   uridine rich small nuclear ribonucleoprotein 
UV    ultraviolet 
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